<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Tuberculosis on VitaminDWiki</title><link>/categories/tuberculosis.html</link><description>Recent content in Tuberculosis on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Tue, 09 Apr 2024 00:00:00 +0000</lastBuildDate><atom:link href="/categories/tuberculosis/index.xml" rel="self" type="application/rss+xml"/><item><title>TB treatment helped by the addition of Vitamin D (100,000 IU bi-weekly) – RCT</title><link>/posts/tb-treatment-helped-by-the-addition-of-vitamin-d-100000-iu-bi-weekly-rct.html</link><pubDate>Tue, 09 Apr 2024 00:00:00 +0000</pubDate><guid>/posts/tb-treatment-helped-by-the-addition-of-vitamin-d-100000-iu-bi-weekly-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#effect-of-adjunct-vitamin-d-treatment-in-vitamin-d-deficient-pulmonary-tuberculosis-patients-a-randomized-double-blind-active-controlled-clinical-trial">Effect of adjunct Vitamin D treatment in vitamin D deficient pulmonary tuberculosis patients: A randomized, double blind, active controlled clinical trial&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="effect-of-adjunct-vitamin-d-treatment-in-vitamin-d-deficient-pulmonary-tuberculosis-patients-a-randomized-double-blind-active-controlled-clinical-trial">Effect of adjunct Vitamin D treatment in vitamin D deficient pulmonary tuberculosis patients: A randomized, double blind, active controlled clinical trial&lt;/h4>
&lt;p>Indian J Tuberc. 2024 Apr;71(2):170-178. &lt;a href="https://doi.org/10.1016/j.ijtb.2023.04.026.">doi: 10.1016/j.ijtb.2023.04.026.&lt;/a> Epub 2023 Apr 29.&lt;/p>
&lt;p>Harish Chandra 1, Adil Rahman 2, Prashant Yadav 3, Geeta Maurya 4, Sushil Kumar Shukla 5&lt;/p>
&lt;p>Background: Since, Vitamin D &lt;span>[1α,25(OH)2D)]&lt;/span> enhances antimicrobial activity of Innate immunity and modulate Adaptive immune responses, simultaneously, so it play a potential role for balanced immune activity against Mycobacterium tuberculosis and restricting tissue injuries within the TB patients.(Chun et al., 2011) 9 We aimed to determine the role of adjunct Vitamin D treatment on the outcome of pulmonary tuberculosis patients and evaluated the effect of Vitamin D administration on Differential Leucocyte Count, Erythrocyte Sedimentation Rate, serum Adenosine deaminase, serum C- reactive protein, Oxygen saturation (SpO2) and Body Weight in Vitamin D deficient pulmonary tuberculosis patients.&lt;/p></description></item><item><title>TB again not prevented by a small amount of Vitamin D – RCT</title><link>/posts/tb-again-not-prevented-by-a-small-amount-of-vitamin-d-rct.html</link><pubDate>Thu, 10 Aug 2023 00:00:00 +0000</pubDate><guid>/posts/tb-again-not-prevented-by-a-small-amount-of-vitamin-d-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-supplementation-to-prevent-tuberculosis-infection-in-south-african-schoolchildren-multicenter-phase-3-double-blind-randomized-placebo-controlled-trial-vidikids">Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-supplementation-to-prevent-tuberculosis-infection-in-south-african-schoolchildren-multicenter-phase-3-double-blind-randomized-placebo-controlled-trial-vidikids">Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids)&lt;/h4>
&lt;p>Int J Infect Dis. 2023 Sep;134:63-70. &lt;a href="https://doi.org/10.1016/j.ijid.2023.05.010">doi: 10.1016/j.ijid.2023.05.010&lt;/a>&lt;/p>
&lt;p>Keren Middelkoop 1, Justine Stewart 1, Neil Walker 2, Carmen Delport 3, David A Jolliffe 4, Anna K Coussens 5, James Nuttall 6, Jonathan C Y Tang 7, William D Fraser 7, Christopher J Griffiths 2, Geeta Trilok Kumar 8, Suzanne Filteau 9, Richard L Hooper 2, Robert J Wilkinson 10, Linda-Gail Bekker 3, Adrian R Martineau 11&lt;/p></description></item><item><title>Tuberculosis not prevented by a tiny amount of vitamin D (equiv to 1,400 IU daily) – RCT</title><link>/posts/tuberculosis-not-prevented-by-a-tiny-amount-of-vitamin-d-equiv-to-1400-iu-daily-rct.html</link><pubDate>Mon, 22 May 2023 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-not-prevented-by-a-tiny-amount-of-vitamin-d-equiv-to-1400-iu-daily-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-supplementation-to-prevent-tuberculosis-infection-in-south-african-schoolchildren-multicentre-phase-3-double-blind-randomised-placebo-controlled-trial-vidikids">Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicentre phase 3 double-blind randomised placebo-controlled trial (ViDiKids)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-supplementation-to-prevent-tuberculosis-infection-in-south-african-schoolchildren-multicentre-phase-3-double-blind-randomised-placebo-controlled-trial-vidikids">Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicentre phase 3 double-blind randomised placebo-controlled trial (ViDiKids)&lt;/h4>
&lt;p>Int J Infect Dis. 2023 May 19;S1201-9712(23)00562-3. &lt;a href="https://doi.org/10.1016/j.ijid.2023.05.010">doi: 10.1016/j.ijid.2023.05.010&lt;/a>&lt;/p>
&lt;p>Keren Middelkoop 1, Justine Stewart 1, Neil Walker 2, Carmen Delport 3, David A Jolliffe 4, Anna K Coussens 5, James Nuttall 6, Jonathan C Y Tang 7, William D Fraser 7, Christopher J Griffiths 2, Geeta Trilok Kumar 8, Suzanne Filteau 9, Richard L Hooper 2, Robert J Wilkinson 10, Linda-Gail Bekker 3, Adrian R Martineau 11&lt;/p></description></item><item><title>HIV patients with low Vitamin A were 3.6 X more likely to get Tuberculosis</title><link>/posts/hiv-patients-with-low-vitamin-a-were-36-x-more-likely-to-get-tuberculosis.html</link><pubDate>Mon, 19 Dec 2022 00:00:00 +0000</pubDate><guid>/posts/hiv-patients-with-low-vitamin-a-were-36-x-more-likely-to-get-tuberculosis.html</guid><description>&lt;h4 id="the-impact-of-vitamin-a-deficiency-on-tuberculosis-progression">The Impact of Vitamin A Deficiency on Tuberculosis Progression&lt;/h4>
&lt;p>Clinical Infectious Diseases, Volume 75, Issue 12, 15 December 2022, Pages 2178–2185, &lt;a href="https://doi.org/10.1093/cid/ciac326">https://doi.org/10.1093/cid/ciac326&lt;/a>&lt;/p>
&lt;p>Brendan K Podell, Omowunmi Aibana, Chuan-Chin Huang, James E DiLisio, Macallister C Harris, David F Ackart, Kody Armann, Alexander Grover, Patrice Severe, Marc Antoine Jean Juste&lt;/p>
&lt;p>Background&lt;/p>
&lt;p>Although previous studies have shown that vitamin A deficiency is associated with incident tuberculosis (TB) disease, the direction of the association has not been established. We investigated the impact of vitamin A deficiency on TB disease progression.&lt;/p></description></item><item><title>Many reasons to believe that Tuberculosis is an Autoimmune disease</title><link>/posts/many-reasons-to-believe-that-tuberculosis-is-an-autoimmune-disease.html</link><pubDate>Thu, 23 Jun 2022 00:00:00 +0000</pubDate><guid>/posts/many-reasons-to-believe-that-tuberculosis-is-an-autoimmune-disease.html</guid><description>&lt;h4 id="tuberculosis-and-autoimmunity">Tuberculosis and Autoimmunity&lt;/h4>
&lt;p>Pathophysiology. 2022 Jun 13;29(2):298-318. &lt;a href="https://doi.org/10.3390/pathophysiology29020022.">doi: 10.3390/pathophysiology29020022.&lt;/a>&lt;/p>
&lt;p>Irina V Belyaeva 1, Anna N Kosova 1, Andrei G Vasiliev 1&lt;/p>
&lt;h4 id="pdf-table-of-contents">PDF Table of Contents&lt;/h4>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/dutch.pdf" alt="image" width="600">
&lt;p>Tuberculosis remains a common and dangerous chronic bacterial infection worldwide. It is long-established that pathogenesis of many autoimmune diseases is mainly promoted by inadequate immune responses to bacterial agents, among them Mycobacterium tuberculosis. Tuberculosis is a multifaceted process having many different outcomes and complications. Autoimmunity is one of the processes characteristic of tuberculosis; the presence of autoantibodies was documented by a large amount of evidence. The role of autoantibodies in pathogenesis of tuberculosis is not quite clear and widely disputed. They are regarded as:&lt;/p></description></item><item><title>Vitamin D fights Tuberculosis by reducing Calcium</title><link>/posts/vitamin-d-fights-tuberculosis-by-reducing-calcium.html</link><pubDate>Mon, 28 Feb 2022 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-fights-tuberculosis-by-reducing-calcium.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d3-promotes-autophagy-in-thp-1-cells-infected-with-mycobacterium-tuberculosis">Vitamin D3 promotes autophagy in THP-1 cells infected with Mycobacterium tuberculosis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d3-promotes-autophagy-in-thp-1-cells-infected-with-mycobacterium-tuberculosis">Vitamin D3 promotes autophagy in THP-1 cells infected with Mycobacterium tuberculosis&lt;/h4>
&lt;p>Exp Ther Med. 2022 Mar;23(3):240. &lt;a href="https://doi.org/10.3892/etm.2022.11165.">doi: 10.3892/etm.2022.11165.&lt;/a> Epub 2022 Jan 25.&lt;/p>
&lt;p>Yiming Wu 1 2, Xue Lin 1 2, Fuyang Song 1 2, Di Xue 1 2, Yujiong Wang 1 2&lt;/p>
&lt;p>(img type=&amp;ldquo;attId&amp;rdquo; attId=&amp;ldquo;17131&amp;rdquo; width=&amp;ldquo;500&amp;rdquo;}&lt;/p>
&lt;p>(img type=&amp;ldquo;attId&amp;rdquo; attId=&amp;ldquo;17132&amp;rdquo; width=&amp;ldquo;500&amp;rdquo;}&lt;/p>
&lt;p>Tuberculosis (TB) is a major disease that causes mortality worldwide. The lethality of this disease is a result of the contagious bacteria Mycobacterium tuberculosis (M.tb). Infection can inhibit phagosomal maturation, with M.tb mainly attacking macrophages and inhibiting autophagy and apoptosis. Vitamin D has been used to treat tuberculosis, whereby the active metabolite, 1,25-dihydroxyvitamin D, may enhance the immune response to M.tb. Moreover, macrophages infected with M.tb have a high demand for Ca2+. However, the mechanisms by which vitamin D3 protects against and treats TB remain unclear. In the present study, MTT assay showed that vitamin D3 decreased the viability of THP-1 cells in a dose- and time-dependent manner. Autophagy-related factors in THP-1 cells infected with M.tb were analyzed by western blotting and RT-qPCR and the results demonstrated that vitamin D3 significantly increased the expression level of p62, LC3Ⅱ/LC3Ⅰ, Beclin-1, ATG-5 and AMPK in THP-1 cells following M.tb infection.&lt;/p></description></item><item><title>Tuberculosis treatment helped a bit by a bit of Vitamin D - RCT</title><link>/posts/tuberculosis-treatment-helped-a-bit-by-a-bit-of-vitamin-d-rct.html</link><pubDate>Thu, 24 Feb 2022 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-treatment-helped-a-bit-by-a-bit-of-vitamin-d-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#effects-of-vitamin-d-supplementation-on-resolution-of-fever-and-cough-in-children-with-pulmonary-tuberculosis-a-randomized-double-blind-controlled-trial-in-indonesia">Effects of Vitamin D supplementation on resolution of fever and cough in children with pulmonary tuberculosis: A randomized double-blind controlled trial in Indonesia&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="effects-of-vitamin-d-supplementation-on-resolution-of-fever-and-cough-in-children-with-pulmonary-tuberculosis-a-randomized-double-blind-controlled-trial-in-indonesia">Effects of Vitamin D supplementation on resolution of fever and cough in children with pulmonary tuberculosis: A randomized double-blind controlled trial in Indonesia&lt;/h4>
&lt;p>J Glob Health. 2022 Feb 18;12:04015. &lt;a href="https://doi.org/10.7189/jogh.12.04015.">doi: 10.7189/jogh.12.04015.&lt;/a> eCollection 2022.&lt;/p>
&lt;p>Lianda Tamara 1 2, Cissy B Kartasasmita 1, Anggraini Alam 1, Dida A Gurnida 1&lt;/p>
&lt;p>&lt;strong>Vitamin D levels did not drop as much in those getting 1,000 IU&lt;/strong>&lt;/p></description></item><item><title>Latent Tuberculosis 44 percent less likely if Vitamin D more than 30 ng - 14th meta-analysis</title><link>/posts/latent-tuberculosis-44-percent-less-likely-if-vitamin-d-more-than-30-ng-14th-meta-analysis.html</link><pubDate>Mon, 31 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/latent-tuberculosis-44-percent-less-likely-if-vitamin-d-more-than-30-ng-14th-meta-analysis.html</guid><description>&lt;h4 id="vitamin-d-and-the-risk-of-latent-tuberculosis-infection-a-systematic-review-and-meta-analysis">Vitamin D and the risk of latent tuberculosis infection: a systematic review and meta-analysis&lt;/h4>
&lt;p>BMC Pulmonary Medicine(2022) 22:39 &lt;a href="https://doi.org/10.1186/s12890-022-01830-5">https://doi.org/10.1186/s12890-022-01830-5&lt;/a>&lt;/p>
&lt;p>Yan Cao11, Xinjing Wang11, Ping Liu3t, Yue Su , Haotian Yu* and Jingli Du1*&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/tb-fig-3.jpg" alt="image" width="600">
&lt;p>Objective: Latent tuberculosis infection (LTBI) may be a risk of developing tuberculosis (TB) and thus a health hazard. The aim of this meta-analysis is to explore the association between vitamin D and LTBI.&lt;/p>
&lt;p>Methods: Databases including PubMed, Embase, Scopus, and ProQuest were electronically searched to identify observational or interventional studies that reported the association between vitamin D and LTBI. The retrieval time is limited from inception to 30 September 2021. Two reviewers independently screened literature, extracted data, and assessed risk bias of included studies. Meta-analysis was performed by using STATA 12.0 software.&lt;/p></description></item><item><title>No tuberculosis if more than 80 ng of vitamin D (cattle)</title><link>/posts/no-tuberculosis-if-more-than-80-ng-of-vitamin-d-cattle.html</link><pubDate>Sun, 16 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/no-tuberculosis-if-more-than-80-ng-of-vitamin-d-cattle.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#reduced-levels-of-serum-25ohd-3-are-associated-with-tuberculosis-positive-cattle-under-conditions-of-high-natural-exposure-to-mycobacterium-bovis">Reduced levels of serum 25(OH)D 3 are associated with tuberculosis positive cattle under conditions of high natural exposure to Mycobacterium bovis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#other-references">Other references&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="reduced-levels-of-serum-25ohd-3-are-associated-with-tuberculosis-positive-cattle-under-conditions-of-high-natural-exposure-to-mycobacterium-bovis">Reduced levels of serum 25(OH)D 3 are associated with tuberculosis positive cattle under conditions of high natural exposure to Mycobacterium bovis&lt;/h4>
&lt;p>Comp Immunol Microbiol Infect Dis&amp;hellip; 2022 Jan 10;81:101746. &lt;a href="https://doi.org/10.1016/j.cimid.2022.101746">doi: 10.1016/j.cimid.2022.101746&lt;/a>&lt;/p>
&lt;p>Sofía López-Constantino 1, Evaristo A Barragan 2, Edgar Alfonseca-Silva 3&lt;/p>
&lt;p>Serum vitamin D (25(OH)D3) concentrations of &amp;lt; 30 ng/mL in cattle are insufficient to induce an adequate immune response against intracellular pathogens, which suggests that the efficacy of the immune response may be highly dependent on the bioavailability of 25(OH)D3. This study shows an overview of both in vitro and in vivo 25(OH)D3-mediated immune modulation amongst dairy cattle naturally exposed to M. bovis. Tuberculin status was confirmed by interferon gamma release assay (IGRA), and natural exposure was demonstrated by polymerase chain reaction (PCR). Tuberculin (-) cattle have a higher serum concentration of 25(OH)D3 (X¯= 87.12 ng/mL) when compared to tuberculin (+) cattle (X¯ = 45.86 ng/mL). Reduced serum 25(OH)D3 levels are associated with the presence of bovine TB, and &lt;strong>serum 25(OH)D3 levels of &amp;gt; 80 ng/mL are necessary to counteract infection by M. bovis&lt;/strong> . Kill assays were performed to evaluate in vitro 25(OH)D3 modulation of intracellular M. bovis growth in bovine macrophages, which showed that reduced serum 25(OH)D3 levels are associated with diminished mycobactericidal capacity in this experimental model. On the other hand, increased 25(OH)D3 in culture media enhances phagocytosis and nitric oxide production, which in turn improves capacity to combat M. bovis.&lt;/p></description></item><item><title>HIV, TB, Malaria more important than COVID to lower Africa</title><link>/posts/hiv-tb-malaria-more-important-than-covid-to-lower-africa.html</link><pubDate>Tue, 21 Dec 2021 00:00:00 +0000</pubDate><guid>/posts/hiv-tb-malaria-more-important-than-covid-to-lower-africa.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#relative-burdens-of-the-covid-19-malaria-tuberculosis-and-hivaids-epidemics-in-sub-saharan-africa">Relative Burdens of the COVID-19, Malaria, Tuberculosis, and HIV/AIDS Epidemics in Sub-Saharan Africa&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#note-vitamin-d-may-fight-all-4-health-problems">Note: Vitamin D may fight all 4 health problems&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="relative-burdens-of-the-covid-19-malaria-tuberculosis-and-hivaids-epidemics-in-sub-saharan-africa">Relative Burdens of the COVID-19, Malaria, Tuberculosis, and HIV/AIDS Epidemics in Sub-Saharan Africa&lt;/h4>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/africa-pie-chart-mortlity.jpg" alt="image" width="400">
&lt;p>Am. J. Trop. Med. Hyg., 105(6), 2021,pp.1510-1515 doi:10.4269/ajtmh.21-0899&lt;/p>
&lt;p>David Bell1 &lt;a href="mailto:bell00david@gmail.com">bell00david@gmail.com&lt;/a> and Kristian Schultz Hansen2,3&lt;/p>
&lt;p>1Independent Consultant, Issaquah, Washington;&lt;/p>
&lt;p>2Department of Public Health and Centre for Health Economics and Policy, University of Copenhagen, Copenhagen, Denmark;&lt;/p>
&lt;p>3The National Research Center of Working Environment, Copenhagen, Denmark&lt;/p></description></item><item><title>Those with TB were 3.2 X more likely to have low vitamin D – 13th meta-analysis</title><link>/posts/those-with-tb-were-32-x-more-likely-to-have-low-vitamin-d-13th-meta-analysis.html</link><pubDate>Wed, 20 Oct 2021 00:00:00 +0000</pubDate><guid>/posts/those-with-tb-were-32-x-more-likely-to-have-low-vitamin-d-13th-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#association-of-vitamin-d-deficiency-with-pulmonary-tuberculosis-a-systematic-review-and-meta-analysis">Association of Vitamin D Deficiency With Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="association-of-vitamin-d-deficiency-with-pulmonary-tuberculosis-a-systematic-review-and-meta-analysis">Association of Vitamin D Deficiency With Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis&lt;/h4>
&lt;p>Cureus 13(9): e17883. doi:10.7759/cureus.17883&lt;/p>
&lt;p>Sunam Kafle, Anjan Kumar Basnet, Kumar Karki, Manusha Thapa Magar, Shumneva Shrestha, Randhir S. Yadav&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/tb-meta.jpg" alt="image" width="350">
&lt;p>Pulmonary tuberculosis, caused by Mycobacterium tuberculosis, is a significant public health issue, especially in developing countries, affecting millions of people every year. Despite the development of many antitubercular antibiotics and increased awareness of preventive methods, it is still a major cause of mortality worldwide. Vitamin D, a micronutrient known to have a major role in bone and calcium metabolism, has also shown its immunomodulatory effects to suppress mycobacterial growth. We conducted a systematic review and meta-analysis of the available evidence to explore the association between vitamin D levels and tuberculosis. We performed a systematic search for articles from inception to May 2021 in multiple databases.&lt;/p></description></item><item><title>TB not prevented by a small amount of Vitamin D (2,000 IU daily average, Mongolia) – RCT</title><link>/posts/tb-not-prevented-by-a-small-amount-of-vitamin-d-2000-iu-daily-average-mongolia-rct.html</link><pubDate>Sun, 26 Sep 2021 00:00:00 +0000</pubDate><guid>/posts/tb-not-prevented-by-a-small-amount-of-vitamin-d-2000-iu-daily-average-mongolia-rct.html</guid><description/></item><item><title>Tuberculosis still associated with low vitamin D – 12th meta-analysis</title><link>/posts/tuberculosis-still-associated-with-low-vitamin-d-12th-meta-analysis.html</link><pubDate>Fri, 11 Jun 2021 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-still-associated-with-low-vitamin-d-12th-meta-analysis.html</guid><description/></item><item><title>Higher risk of pulmonary tuberculosis if any of 3 vitamin D genes are poor</title><link>/posts/higher-risk-of-pulmonary-tuberculosis-if-any-of-3-vitamin-d-genes-are-poor.html</link><pubDate>Wed, 21 Apr 2021 00:00:00 +0000</pubDate><guid>/posts/higher-risk-of-pulmonary-tuberculosis-if-any-of-3-vitamin-d-genes-are-poor.html</guid><description>&lt;h4 id="association-of-vitamin-d-pathway-genes-polymorphisms-with-pulmonary-tuberculosis-susceptibility-in-a-chinese-population">Association of vitamin D pathway genes polymorphisms with pulmonary tuberculosis susceptibility in a Chinese population&lt;/h4>
&lt;p>Genes &amp;amp; Nutrition volume 16, Article number: 6 (2021) &lt;a href="https://doi.org/10.1186/s12263-021-00687-3">https://doi.org/10.1186/s12263-021-00687-3&lt;/a>&lt;/p>
&lt;p>Tian-Ping Zhang, Shuang-Shuang Chen, Gen-You Zhang, Si-Jiu Shi, Li Wei &amp;amp; Hong-Miao Li&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
#### Low vitamin D in the blood is probably more important than poor genes
&lt;ul>
&lt;li>&lt;a href="/posts/tuberculosis-3x-more-likely-if-less-than-12-ng-of-vitamin-d-meta-analysis">Tuberculosis 3X more likely if less than 12 ng of Vitamin D - meta-analysis Sept 2019&lt;/a>&lt;/li>
&lt;/ul></description></item><item><title>Tuberculosis – perhaps all forms are associated with low vitamin D</title><link>/posts/tuberculosis-perhaps-all-forms-are-associated-with-low-vitamin-d.html</link><pubDate>Wed, 09 Dec 2020 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-perhaps-all-forms-are-associated-with-low-vitamin-d.html</guid><description/></item><item><title>Low vitamin D with HIV increases risk of infections – TB by 3.5X, CMV by 10.1X</title><link>/posts/low-vitamin-d-with-hiv-increases-risk-of-infections-tb-by-35x-cmv-by-101x.html</link><pubDate>Fri, 14 Aug 2020 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-with-hiv-increases-risk-of-infections-tb-by-35x-cmv-by-101x.html</guid><description/></item><item><title>Immunologic Effects of Vitamin D on Human Health and Disease - Holick</title><link>/posts/immunologic-effects-of-vitamin-d-on-human-health-and-disease-holick.html</link><pubDate>Wed, 15 Jul 2020 00:00:00 +0000</pubDate><guid>/posts/immunologic-effects-of-vitamin-d-on-human-health-and-disease-holick.html</guid><description>&lt;h3 id="physiology-of-vitamin-d">Physiology of Vitamin D&lt;/h3>
&lt;h4 id="sources-synthesis-and-metabolism-of-vitamin-d">Sources, Synthesis, and Metabolism of Vitamin D&lt;/h4>
&lt;p>Human gets vitamin D from sunlight, diet, and supplements. There are two major forms of vitamin D: vitamin D2 and vitamin D3. Vitamin D2 is synthesized from ergosterol and found in yeast, sun dried and ultraviolet irradiated mushrooms, and plants. Vitamin D3 is synthesized endogenously from 7-dehydrocholesterol in the skin and found naturally in cod liver oil and oily fish. After entering the circulation, vitamin D (D represents either or both vitamin D2 and vitamin D3) is metabolized by the vitamin D-25-hydroxylase (CYP2R1) in the liver to 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span>. 25(OH)D is further metabolized by the enzyme 25-hydroxyvitamin D-1a-hydroxylase (CYP27B1) to the active form, 1,25-dihydroxyvitamin D &lt;span>[1,25(OH)2D]&lt;/span> &lt;sup>[2,6]&lt;/sup>. 1,25(OH)2D exerts its physiologic functions in the target tissue by binding to the vitamin D receptor (VDR) in the nucleus where it leads to up- or down- regulation of a multitude of genes &lt;sup>[7]&lt;/sup>. It should be noted that the main site of conversion of 25(OH)D into the systemically bioavailable 1,25(OH)2D is the kidneys. CYP27B1 is also expressed by many other tissues including activated macrophages, parathyroid glands, microglia, breast, colon, and keratinocytes where 1,25(OH)2D is produced and exerts its autocrine and paracrine functions &lt;sup>[1,4,5]&lt;/sup>.&lt;/p></description></item><item><title>Vitamin D does not reduce Infectious Disease when not enough is given</title><link>/posts/vitamin-d-does-not-reduce-infectious-disease-when-not-enough-is-given.html</link><pubDate>Wed, 12 Feb 2020 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-does-not-reduce-infectious-disease-when-not-enough-is-given.html</guid><description/></item><item><title>Poor Tuberculosis outcomes if low vitamin D and diabetic</title><link>/posts/poor-tuberculosis-outcomes-if-low-vitamin-d-and-diabetic.html</link><pubDate>Thu, 05 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/poor-tuberculosis-outcomes-if-low-vitamin-d-and-diabetic.html</guid><description/></item><item><title>Tuberculosis 3X more likely if less than 12 ng of Vitamin D - meta-analysis</title><link>/posts/tuberculosis-3x-more-likely-if-less-than-12-ng-of-vitamin-d-meta-analysis.html</link><pubDate>Wed, 02 Oct 2019 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-3x-more-likely-if-less-than-12-ng-of-vitamin-d-meta-analysis.html</guid><description/></item><item><title>Tuberculosis 2.3 X more likely if low vitamin D</title><link>/posts/tuberculosis-23-x-more-likely-if-low-vitamin-d.html</link><pubDate>Sun, 21 Jul 2019 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-23-x-more-likely-if-low-vitamin-d.html</guid><description/></item><item><title>TB patients had low Vitamin D and poor Vitamin D receptor</title><link>/posts/tb-patients-had-low-vitamin-d-and-poor-vitamin-d-receptor.html</link><pubDate>Mon, 01 Jul 2019 00:00:00 +0000</pubDate><guid>/posts/tb-patients-had-low-vitamin-d-and-poor-vitamin-d-receptor.html</guid><description>&lt;h4 id="household-contacts-have-better-vitamin-d-levels-andmore-activated-vitamin-d-receptors---oct-2019">Household contacts have better Vitamin D levels andmore activated Vitamin D Receptors - Oct 2019&lt;/h4>
&lt;p>&lt;strong>Association of Fok1 VDR polymorphism with Vitamin D and its associated molecules in pulmonary tuberculosis patients and their household contacts.&lt;/strong>&lt;/p>
&lt;p>Sci Rep. 2019 Oct 24;9(1):15251. &lt;a href="https://doi.org/10.1038/s41598-019-51803-8.">doi: 10.1038/s41598-019-51803-8.&lt;/a>&lt;/p>
&lt;p>Panda S1, Tiwari A1, Luthra K1, Sharma SK2, Singh A3.&lt;/p>
&lt;p>1 Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, 110029, India.&lt;/p>
&lt;p>2 Department of Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India.&lt;/p></description></item><item><title>TB not helped by Vitamin D (did not even measure Vit D levels)</title><link>/posts/tb-not-helped-by-vitamin-d-did-not-even-measure-vit-d-levels.html</link><pubDate>Thu, 20 Jun 2019 00:00:00 +0000</pubDate><guid>/posts/tb-not-helped-by-vitamin-d-did-not-even-measure-vit-d-levels.html</guid><description/></item><item><title>Tuberculosis not treated by monthly 140,000 IU (Vitamin D binding protein problem) – RCT</title><link>/posts/tuberculosis-not-treated-by-monthly-140000-iu-vitamin-d-binding-protein-problem-rct.html</link><pubDate>Thu, 13 Jun 2019 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-not-treated-by-monthly-140000-iu-vitamin-d-binding-protein-problem-rct.html</guid><description/></item><item><title>TB and Leprosy are easily confused and associated with Vitamin D Receptor</title><link>/posts/tb-and-leprosy-are-easily-confused-and-associated-with-vitamin-d-receptor.html</link><pubDate>Mon, 10 Jun 2019 00:00:00 +0000</pubDate><guid>/posts/tb-and-leprosy-are-easily-confused-and-associated-with-vitamin-d-receptor.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#tuberculosis-and-leprosy-classical-granulomatous-diseases-in-the-twenty-first-century---july-2015">Tuberculosis and Leprosy: Classical Granulomatous Diseases in the Twenty-First Century - July 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#human-genetics-of-mycobacterial-disease---aug-2018">Human genetics of mycobacterial disease - Aug 2018&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="tuberculosis-and-leprosy-classical-granulomatous-diseases-in-the-twenty-first-century---july-2015">Tuberculosis and Leprosy: Classical Granulomatous Diseases in the Twenty-First Century - July 2015&lt;/h4>
&lt;p>Dermatol Clin. 2015 Jul;33(3):541-62. &lt;a href="https://doi.org/10.1016/j.det.2015.03.016.">doi: 10.1016/j.det.2015.03.016.&lt;/a>&lt;/p>
&lt;p>Scollard DM1, Dacso MM2, Abad-Venida ML3.&lt;/p>
&lt;ul>
&lt;li>
&lt;p>1 National Hansen&amp;rsquo;s Disease Programs, 1770 Physician Park Drive, Baton Rouge, LA 70816, USA. Electronic address: &lt;a href="mailto:dscollard@hrsa.gov">dscollard@hrsa.gov&lt;/a>.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>2 Center for Dermatology and Cosmetic Laser Surgery, 5026 Tennyson Parkway, Plano, TX 75024, USA; Department of Dermatology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9069, USA.&lt;/p></description></item><item><title>Certain types of Tuberculosis are 2X more likely with a poor Vitamin D Receptor</title><link>/posts/certain-types-of-tuberculosis-are-2x-more-likely-with-a-poor-vitamin-d-receptor.html</link><pubDate>Sat, 20 Apr 2019 00:00:00 +0000</pubDate><guid>/posts/certain-types-of-tuberculosis-are-2x-more-likely-with-a-poor-vitamin-d-receptor.html</guid><description/></item><item><title>Oral Vitamin D, the lung microbiome and Tuberculosis</title><link>/posts/oral-vitamin-d-the-lung-microbiome-and-tuberculosis.html</link><pubDate>Sat, 13 Apr 2019 00:00:00 +0000</pubDate><guid>/posts/oral-vitamin-d-the-lung-microbiome-and-tuberculosis.html</guid><description>&lt;p>&lt;strong>Note: Might be possible to get vitamin D directly to the lung microbiome if it were inhaled.&lt;br>
No mention of that possibility in this study&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>&lt;a href="/posts/inhaled-vitamin-d-help-lungs-many-studies">Inhaled vitamin D help lungs - many studies&lt;/a>&lt;/li>
&lt;/ul>
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/vit-d-tb-microbiome-compressed.pdf">Download the PDF from Sci-Hub via VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/tb-triangle.jpg" alt="image" width="700">
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Granuloma formation in tuberculosis involves multiple cell interactions which are affected by commensals in the lung.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>It is possible that lung microbiota changes could affect tuberculous granuloma dynamics.&lt;/p></description></item><item><title>Tuberculosis increased risk if poor Vitamin D receptor varies by race – meta-analysis</title><link>/posts/tuberculosis-increased-risk-if-poor-vitamin-d-receptor-varies-by-race-meta-analysis.html</link><pubDate>Sat, 02 Mar 2019 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-increased-risk-if-poor-vitamin-d-receptor-varies-by-race-meta-analysis.html</guid><description/></item><item><title>Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis</title><link>/posts/tuberculosis-multi-drug-resistant-was-134-x-more-likely-to-be-quickly-cleared-wi-d-meta-analysis.html</link><pubDate>Thu, 07 Feb 2019 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-multi-drug-resistant-was-134-x-more-likely-to-be-quickly-cleared-wi-d-meta-analysis.html</guid><description>&lt;p>&lt;strong>&lt;a href="https://www.qmul.ac.uk/media/news/2019/smd/vitamin-d-helps-treat-lethal-drug-resistant-tb.html">From Press Release&lt;/a>&lt;/strong>&lt;/p>
&lt;p>10.0 million people developed active tuberculosis worldwide in 2017,&lt;/p>
&lt;p>Multi-drug resistant (MDR) TB.occurred in ~500,000 cases. (5%)&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&amp;ldquo;Lead researcher Professor Adrian Martineau from Queen Mary University of London said: &amp;ldquo;Multi-drug resistant TB is on the rise globally. It&amp;rsquo;s notoriously difficult to treat, and it carries a much worse prognosis than standard TB.&amp;rdquo;&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&amp;ldquo;By adding vitamin D to antibiotic treatment, we can boost the immune system to help the body to clear TB bugs, rather than relying on antibiotics on their own to kill the bacteria directly&amp;rdquo;&lt;/p></description></item><item><title>Gout, cholera, scarlet fever, TB all increasing in the UK (low vitamin D)</title><link>/posts/gout-cholera-scarlet-fever-tb-all-increasing-in-the-uk-low-vitamin-d.html</link><pubDate>Sun, 03 Feb 2019 00:00:00 +0000</pubDate><guid>/posts/gout-cholera-scarlet-fever-tb-all-increasing-in-the-uk-low-vitamin-d.html</guid><description>&lt;h4 id="the-victorian-diseases-putting-people-in-merseyside-in-hospitalhttpswwwliverpoolechocouknewsliverpool-newsvictorian-diseases-putting-people-merseyside-15770087">&lt;a href="https://www.liverpoolecho.co.uk/news/liverpool-news/victorian-diseases-putting-people-merseyside-15770087">The Victorian diseases putting people in Merseyside in hospital&lt;/a>&lt;/h4>
&lt;ul>
&lt;li>“… 315 occasions in 2017/18 on which people were treated as inpatients in hospitals in the area for one of 13 Victorian diseases - up from 254 the previous year.&lt;/li>
&lt;/ul>
&lt;p>&lt;strong>The 13 &amp;lsquo;Victorian&amp;rsquo; diseases&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Gout&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Tuberculosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Malnutrition&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Whooping cough&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Measles&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Scurvy&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Typhoid&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Scarlet fever &lt;a href="https://www.bbc.com/news/uk-wales-63950492">UK Dec 2022&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Diphtheria&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Mumps&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Rickets&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Vitamin D deficiency&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Cholera&lt;/p>
&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>“More than half (165) of the finished admission episodes covered by the Merseyside Area Team were for gout….”&lt;/p></description></item><item><title>Catching Tuberculosis from family member 2 X more likely if low vitamin D – meta-analysis</title><link>/posts/catching-tuberculosis-from-family-member-2-x-more-likely-if-low-vitamin-d-meta-analysis.html</link><pubDate>Sat, 01 Dec 2018 00:00:00 +0000</pubDate><guid>/posts/catching-tuberculosis-from-family-member-2-x-more-likely-if-low-vitamin-d-meta-analysis.html</guid><description/></item><item><title>Sleep disorders and Autism, TB, etc. (all have low vitamin D)</title><link>/posts/sleep-disorders-and-autism-tb-etc-all-have-low-vitamin-d.html</link><pubDate>Sun, 09 Sep 2018 00:00:00 +0000</pubDate><guid>/posts/sleep-disorders-and-autism-tb-etc-all-have-low-vitamin-d.html</guid><description>&lt;h4 id="a-cross-syndrome-cohort-comparison-of-sleep-disturbance-in-children-with-smith-magenis-syndrome-angelman-syndrome-autism-spectrum-disorder-and-tuberous-sclerosis-complex">A cross-syndrome cohort comparison of sleep disturbance in children with Smith-Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex.&lt;/h4>
&lt;p>J Neurodev Disord. 2018 Mar 1;10(1):9. &lt;a href="https://doi.org/10.1186/s11689-018-9226-0.">doi: 10.1186/s11689-018-9226-0.&lt;/a>&lt;/p>
&lt;p>Trickett J1,2, Heald M3, Oliver C3, Richards C3.&lt;/p>
&lt;p>1 Department of Health Sciences, College of Life Sciences, George Davies Centre, University of Leicester, Leicester, LE1 7RH, UK. &lt;a href="mailto:jkt12@leicester.ac.uk">jkt12@leicester.ac.uk&lt;/a>.&lt;/p>
&lt;p>2 Cerebra Centre for Neurodevelopmental Disorders, School of Psychology, University of Birmingham, Birmingham, B15 2TT, UK. &lt;a href="mailto:jkt12@leicester.ac.uk">jkt12@leicester.ac.uk&lt;/a>.&lt;/p></description></item><item><title>Tuberculosis in children 1.7 X more likely if low vitamin D – meta-analysis</title><link>/posts/tuberculosis-in-children-17-x-more-likely-if-low-vitamin-d-meta-analysis.html</link><pubDate>Sun, 02 Sep 2018 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-in-children-17-x-more-likely-if-low-vitamin-d-meta-analysis.html</guid><description/></item><item><title>Review of Tuberculosis and Vitamin D</title><link>/posts/review-of-tuberculosis-and-vitamin-d.html</link><pubDate>Tue, 29 May 2018 00:00:00 +0000</pubDate><guid>/posts/review-of-tuberculosis-and-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-and-tuberculosiswhere-next">Vitamin D and tuberculosis:where next?&lt;/h4>
&lt;p>Journal of Internal Medicine, &lt;a href="https://doi.org/10.1111/joim.12777">https://doi.org/10.1111/joim.12777&lt;/a>&lt;/p>
&lt;p>Susanna Brighenti &lt;a href="mailto:susanna.brighenti@ki.se">susanna.brighenti@ki.se&lt;/a> Peter Bergman Adrian R Martineau&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-tuberculosis-and-vitamin-d">Overview Tuberculosis and Vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/pulmonary-tuberculosis-2x-more-likely-if-poor-vitamin-d-receptor-mexico">Pulmonary Tuberculosis 2X more likely if poor Vitamin D Receptor (Mexico) – April 2018&lt;/a>&lt;/p>
&lt;ul>
&lt;li>Note: Receptor limitations have been ignored by most TB studies&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/dickensian-diseases-are-returning-rickets-gout-whooping-cough-tb-etc-low-vitamin-d">Dickensian diseases are returning – rickets, gout, whooping cough, TB, etc. (low vitamin D) &lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/tb-treatment-by-vitamin-d-some-problems-except-for-clinic-c">TB treatment by Vitamin D – some problems, except for Clinic C – June 2017&lt;/a>&lt;/p></description></item><item><title>Pulmonary Tuberculosis 2X more likely if poor Vitamin D Receptor (Mexico)</title><link>/posts/pulmonary-tuberculosis-2x-more-likely-if-poor-vitamin-d-receptor-mexico.html</link><pubDate>Sat, 14 Apr 2018 00:00:00 +0000</pubDate><guid>/posts/pulmonary-tuberculosis-2x-more-likely-if-poor-vitamin-d-receptor-mexico.html</guid><description/></item><item><title>Dickensian diseases are returning – rickets, gout, whooping cough, TB, etc. (low vitamin D)</title><link>/posts/dickensian-diseases-are-returning-rickets-gout-whooping-cough-tb-etc-low-vitamin-d.html</link><pubDate>Sat, 31 Mar 2018 00:00:00 +0000</pubDate><guid>/posts/dickensian-diseases-are-returning-rickets-gout-whooping-cough-tb-etc-low-vitamin-d.html</guid><description/></item><item><title>TB treatment by Vitamin D – some problems, except for Clinic C</title><link>/posts/tb-treatment-by-vitamin-d-some-problems-except-for-clinic-c.html</link><pubDate>Fri, 02 Mar 2018 00:00:00 +0000</pubDate><guid>/posts/tb-treatment-by-vitamin-d-some-problems-except-for-clinic-c.html</guid><description>&lt;h4 id="paradoxical-upgrading-reaction-in-extra-pulmonary-tuberculosis-association-with-vitamin-d-therapy">Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy.&lt;/h4>
&lt;p>Int J Tuberc Lung Dis. 2017 Jun 1;21(6):677-683. &lt;a href="https://doi.org/10.5588/ijtld.16.0927.">doi: 10.5588/ijtld.16.0927.&lt;/a>&lt;/p>
&lt;p>Barr DA &lt;a href="mailto:david.barr@liverpool.ac.uk">david.barr@liverpool.ac.uk&lt;/a>, Coussens AK, Irvine S3, Ritchie ND, Herbert K, Choo-Kang B, Raeside D, Bell DJ, Seaton RA&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/million-tb-deaths-annually-yet-proven-treatments-of-vitamin-d-sunshine-etc-are-not-used">Million TB deaths annually, yet proven treatments of Vitamin D, sunshine, etc are not used – July 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/tuberculosis-100-percent-cure-rate-with-10000-iu-of-vitamin-d-daily-rct-2006">Tuberculosis -100 percent cure rate with 10,000 IU of vitamin D daily – RCT 2006&lt;/a>&lt;/p></description></item><item><title>TB risk in Blacks increased 20 percent having poor Vitamin D Receptors</title><link>/posts/tb-risk-in-blacks-increased-20-percent-having-poor-vitamin-d-receptors.html</link><pubDate>Thu, 26 Oct 2017 00:00:00 +0000</pubDate><guid>/posts/tb-risk-in-blacks-increased-20-percent-having-poor-vitamin-d-receptors.html</guid><description>&lt;h4 id="vitamin-d-receptor-apai-rs7975232-polymorphism-confers-decreased-risk-of-pulmonary-tuberculosis-in-overall-and-african-population-but-not-in-asians-evidence-from-a-meta-analysis">Vitamin D Receptor ApaI (rs7975232) Polymorphism Confers Decreased Risk of Pulmonary Tuberculosis in Overall and African Population, but not in Asians: Evidence from a Meta-analysis&lt;/h4>
&lt;p>Annals of Clinical &amp;amp; Laboratory Science. 47(5):628–637, SEP 2017, DOI: 0091-7370/17/0500-628&lt;/p>
&lt;p>Mohammed Y. Areeshi; Raju K. Mandal; Mohd Wahid; Sajad A. Dar; Arshad Jawed; Mohtashim Lohani; Amir Mahgoub Awadelkareem Abdallah; Saif Khan; Aditya K. Panda; B. N. Mishra; Shafiul Haque&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/tuberculosis-13-times-more-likely-if-poor-vitamin-d-receptor-meta-analysis">Tuberculosis 1.3 times more likely if poor Vitamin D Receptor – meta-analysis Oct 2016&lt;/a>&lt;/p></description></item><item><title>TB not treated by vitamin D given for only 2 months – RCT</title><link>/posts/tb-not-treated-by-vitamin-d-given-for-only-2-months-rct.html</link><pubDate>Sat, 09 Sep 2017 00:00:00 +0000</pubDate><guid>/posts/tb-not-treated-by-vitamin-d-given-for-only-2-months-rct.html</guid><description/></item><item><title>Million TB deaths annually, yet proven treatments of Vitamin D, sunshine, etc are not used</title><link>/posts/million-tb-deaths-annually-yet-proven-treatments-of-vitamin-d-sunshine-etc-are-not-used.html</link><pubDate>Thu, 27 Jul 2017 00:00:00 +0000</pubDate><guid>/posts/million-tb-deaths-annually-yet-proven-treatments-of-vitamin-d-sunshine-etc-are-not-used.html</guid><description>&lt;h4 id="vitamin-d-cod-liver-oil-sunshine-and-phototherapy-safe-effective-and-forgotten-tools-for-treating-and-curing-tuberculosis-infections--a-comprehensive-review">Vitamin D, cod liver oil, sunshine, and phototherapy: Safe, effective and forgotten tools for treating and curing tuberculosis infections − A comprehensive review&lt;/h4>
&lt;p>The Journal of Steroid Biochemistry and Molecular Biology, online 26 July 2017, &lt;a href="https://doi.org/10.1016/j.jsbmb.2017.07.027">https://doi.org/10.1016/j.jsbmb.2017.07.027&lt;/a>&lt;/p>
&lt;p>Patrick J. McCullough a, b, &lt;a href="mailto:Patrick.mccullough@mha.ohio.gov">Patrick.mccullough@mha.ohio.gov&lt;/a> , Douglas S. Lehrer a, b&lt;/p>
&lt;p>a Summit Behavioral Healthcare, Ohio Department of Mental Health and Addiction Services, Cincinnati, Ohio, 45237, USA&lt;/p>
&lt;p>b Department of Psychiatry, Wright State University Boonshoft School of Medicine, Dayton, OH,45435, USA&lt;/p></description></item><item><title>Vitamin D in respiratory diseases – Spring 2017</title><link>/posts/vitamin-d-in-respiratory-diseases-spring-2017.html</link><pubDate>Sun, 09 Apr 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-in-respiratory-diseases-spring-2017.html</guid><description/></item><item><title>Tuberculosis recovery speeded up by single 450,000 IU dose of vitamin D – RCT</title><link>/posts/tuberculosis-recovery-speeded-up-by-single-450000-iu-dose-of-vitamin-d-rct.html</link><pubDate>Tue, 31 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-recovery-speeded-up-by-single-450000-iu-dose-of-vitamin-d-rct.html</guid><description/></item><item><title>Low vitamin D is a risk factor for tuberculosis – meta-analysis</title><link>/posts/low-vitamin-d-is-a-risk-factor-for-tuberculosis-meta-analysis.html</link><pubDate>Thu, 29 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-is-a-risk-factor-for-tuberculosis-meta-analysis.html</guid><description/></item><item><title>8 times less bacteria in blood of HIV patients if Vitamin D levels greater than 30 ng</title><link>/posts/8-times-less-bacteria-in-blood-of-hiv-patients-if-vitamin-d-levels-greater-than-30-ng.html</link><pubDate>Sat, 17 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/8-times-less-bacteria-in-blood-of-hiv-patients-if-vitamin-d-levels-greater-than-30-ng.html</guid><description>&lt;h4 id="optimal-vitamin-d-plasma-levels-are-associated-with-lower-bacterial-dna-translocation-in-hivhepatitis-c-virus-coinfected-patients">Optimal vitamin D plasma levels are associated with lower bacterial DNA translocation in HIV/hepatitis c virus coinfected patients.&lt;/h4>
&lt;p>AIDS. 2016 Apr 24;30(7):1069-74. &lt;a href="https://doi.org/10.1097/QAD.0000000000001007.">doi: 10.1097/QAD.0000000000001007.&lt;/a>&lt;/p>
&lt;p>García-Álvarez M1, Berenguer J, Jiménez-Sousa MÁ, Vázquez-Morón S, Carrero A, Gutiérrez-Rivas M, Aldámiz-Echevarría T, López JC, García-Broncano P, Resino S.&lt;/p>
&lt;p>1aUnit of Viral Infection and Immunity, National Centre of Microbiology. Instituto de Salud Carlos III, Majadahonda,bInfectious Diseases-HIV Unit, Hospital General Universitario &amp;lsquo;Gregorio Marañón&amp;rsquo;cHealth Research Institute &amp;lsquo;Gregorio Marañón&amp;rsquo;, Madrid, Spain.&lt;/p></description></item><item><title>Boron and Granulomas (TB, Rheumatoid arthritis, Crohn's, Rheumatic Fever etc.) - 2015</title><link>/posts/boron-and-granulomas-tb-rheumatoid-arthritis-crohns-rheumatic-fever-etc-2015.html</link><pubDate>Mon, 14 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/boron-and-granulomas-tb-rheumatoid-arthritis-crohns-rheumatic-fever-etc-2015.html</guid><description/></item><item><title>Tuberculosis 1.3 times more likely if poor Vitamin D Receptor – meta-analysis</title><link>/posts/tuberculosis-13-times-more-likely-if-poor-vitamin-d-receptor-meta-analysis.html</link><pubDate>Sat, 12 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-13-times-more-likely-if-poor-vitamin-d-receptor-meta-analysis.html</guid><description>&lt;h4 id="vitamin-d-receptor-gene-foki-polymorphisms-and-tuberculosis-susceptibility-a-meta-analysis">Vitamin D receptor gene FokI polymorphisms and tuberculosis susceptibility: a meta-analysis.&lt;/h4>
&lt;p>Arch Med Sci. 2016 Oct 1;12(5):1118-1134. Epub 2016 May 20.&lt;/p>
&lt;p>Cao Y1, Wang X1, Cao Z1, Cheng X1.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:650px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-tuberculosis-and-vitamin-d">Overview Tuberculosis and Vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/tuberculosis-45x-more-likely-if-vitamin-d-less-than-10-nanogram-meta-analysis">Tuberculosis 4.5X more likely if vitamin D less than 10 nanogram – meta-analysis May 2015&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/tuberculosis-genes-and-vitamin-d-meta-analysis">Tuberculosis, genes and vitamin D – Meta-Analysis Dec 2013&lt;/a>&lt;/p>
&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>More genes than just the Vitamin D Receptor&lt;/p>
&lt;/blockquote></description></item><item><title>Tuberculosis treatment greatly helped by injection of 200,000 IU of vitamin D – RCT</title><link>/posts/tuberculosis-treatment-greatly-helped-by-injection-of-200000-iu-of-vitamin-d-rct.html</link><pubDate>Tue, 05 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-treatment-greatly-helped-by-injection-of-200000-iu-of-vitamin-d-rct.html</guid><description/></item><item><title>Tuberculosis -100 percent cure rate with 10,000 IU of vitamin D daily – RCT 2006</title><link>/posts/tuberculosis-100-percent-cure-rate-with-10000-iu-of-vitamin-d-daily-rct-2006.html</link><pubDate>Sun, 03 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-100-percent-cure-rate-with-10000-iu-of-vitamin-d-daily-rct-2006.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-effect-of-vitamin-d-as-supplementary-treatment-in-patients-with-moderately-advanced-pulmonary-tuberculous-lesion">The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-effect-of-vitamin-d-as-supplementary-treatment-in-patients-with-moderately-advanced-pulmonary-tuberculous-lesion">The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion.&lt;/h4>
&lt;p>Acta Med Indones. 2006 Jan-Mar;38(1):3-5.&lt;/p>
&lt;p>Nursyam EW1, Amin Z, Rumende CM.&lt;/p>
&lt;p>1Departement of Internal Medicine, Faculty of Medicine, University of Indonesia-dr.Cipto Mangunkusumo Hospital, Jakarta.&lt;/p>
&lt;p>AIM:&lt;/p>
&lt;p>to compare the vitamin D group of pulmonary tuberculosis patients with a placebo group in terms of clinical improvement, nutritional status, sputum conversion, and radiological improvement.&lt;/p></description></item><item><title>Tuberculosis not treated by lots of vitamin D for 16 weeks – RCT</title><link>/posts/tuberculosis-not-treated-by-lots-of-vitamin-d-for-16-weeks-rct.html</link><pubDate>Fri, 25 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-not-treated-by-lots-of-vitamin-d-for-16-weeks-rct.html</guid><description/></item><item><title>Tuberculosis should be treated with vitamin D (tiny abstract) – review</title><link>/posts/tuberculosis-should-be-treated-with-vitamin-d-tiny-abstract-review.html</link><pubDate>Tue, 12 May 2015 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-should-be-treated-with-vitamin-d-tiny-abstract-review.html</guid><description>&lt;h4 id="vitamin-d-supplementation-a-comprehensive-review-on-supplementation-for-tuberculosis-prophylaxis">Vitamin D supplementation: a comprehensive review on supplementation for tuberculosis prophylaxis.&lt;/h4>
&lt;p>Expert Rev Respir Med. 2015 May 9:1-7. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Turnbull ER1, Drobniewski F.&lt;/p>
&lt;p>Vitamin D plays a large role in the innate immune response against Mycobacterium tuberculosis (MTB) infection, activation and progression. Likewise, vitamin D deficiency is shown by evidence presented here to be a known risk factor for developing both MTB infection and active tuberculosis (TB). This comprehensive review discusses the evidence and remaining questions regarding vitamin D supplementation as a prophylactic measure in those who are at high risk of MTB infection and active TB. Vitamin D supplementation is routinely prescribed for osteoporosis prevention; yet, guidelines are lacking for its prescription for TB prevention, despite the adverse effects being rare. &lt;strong>Policymakers are urged here to review the literature and provide urgent guidelines on vitamin D supplementation for TB prophylaxis.&lt;/strong>&lt;/p></description></item><item><title>Tuberculosis 4.5X more likely if vitamin D less than 10 nanogram – meta-analysis</title><link>/posts/tuberculosis-45x-more-likely-if-vitamin-d-less-than-10-nanogram-meta-analysis.html</link><pubDate>Wed, 06 May 2015 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-45x-more-likely-if-vitamin-d-less-than-10-nanogram-meta-analysis.html</guid><description>&lt;h3 id="a-serum-vitamin-d-level-25nmoll-pose-high-tuberculosis-risk-a-meta-analysis">A serum vitamin d level &amp;lt;25nmol/l pose high tuberculosis risk: a meta-analysis.&lt;/h3>
&lt;p>PLoS One. 2015 May 4;10(5):e0126014. &lt;a href="https://doi.org/10.1371/journal.pone.0126014.">doi: 10.1371/journal.pone.0126014.&lt;/a> eCollection 2015.&lt;/p>
&lt;p>Zeng J1, Wu G2, Yang W2, Gu X2, Liang W2, Yao Y2, Song Y3.&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/tb-5-10-ng.jpg" alt="image" width="1000">
&lt;p>BACKGROUND:&lt;/p>
&lt;p>Low serum Vitamin D is considered to be associated with tuberculosis while the &amp;ldquo;dangerous&amp;rdquo; level was not clear. The aim of this study was to identify the association between tuberculosis and serum Vitamin D levels via synthesis of available evidence.&lt;/p></description></item><item><title>Tuberculosis not treated by 7,000 IU Vitamin D daily average for 6 weeks – RCT</title><link>/posts/tuberculosis-not-treated-by-7000-iu-vitamin-d-daily-average-for-6-weeks-rct.html</link><pubDate>Mon, 13 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-not-treated-by-7000-iu-vitamin-d-daily-average-for-6-weeks-rct.html</guid><description>&lt;h4 id="adjunctive-vitamin-d-for-treatment-of-active-tuberculosis-in-india-a-randomised-double-blind-placebo-controlled-trial">Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial.&lt;/h4>
&lt;p>Lancet Infect Dis. 2015 Apr 8. pii: S1473-3099(15)70053-8. &lt;a href="https://doi.org/10.1016/S1473-3099(15)70053-8.">doi: 10.1016/S1473-3099(15)70053-8.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Daley P1, Jagannathan V2, John KR3, Sarojini J2, Latha A2, Vieth R4, Suzana S2, Jeyaseelan L2, Christopher DJ2, Smieja M5, Mathai D6.&lt;/p>
&lt;p>BACKGROUND:&lt;/p>
&lt;p>Vitamin D has immunomodulatory effects that might aid clearance of mycobacterial infection. We aimed to assess whether vitamin D supplementation would reduce time to sputum culture conversion in patients with active tuberculosis.&lt;/p></description></item><item><title>TB lowers vitamin D, then HIV lowers it even more - 2014</title><link>/posts/tb-lowers-vitamin-d-then-hiv-lowers-it-even-more-2014.html</link><pubDate>Tue, 20 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/tb-lowers-vitamin-d-then-hiv-lowers-it-even-more-2014.html</guid><description>&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/tb-dbp.jpg" alt="image">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/hiv-and-tb.jpg" alt="image">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/new-tb.jpg" alt="image">
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/anti-inflammatory-and-antimicrobial-actions-of-vitamin-d-in-combating-tb-or-hiv---copy.pdf">Download the PDF from VitaminDWiki.&lt;/a>&lt;/strong>&lt;/p>
&lt;hr>
&lt;p>Vitamin D treats both TB and HIV&lt;/p>
&lt;p>Very low vitamin D leads to many other diseases&lt;/p>
&lt;p>A person with both TB and HIV absolutely, positively should increase their levels of vitamin D.&lt;/p>
&lt;p>It will not only treat both but till decrease the risk of getting other diseases as well&lt;/p>
&lt;p>&lt;strong>See also VitaminDWiki&lt;/strong>&lt;/p>
&lt;p>&lt;a href="/posts/overview-hiv-and-vitamin-d">Overview HIV and vitamin D&lt;/a>&lt;/p>
&lt;p>&lt;a href="/posts/overview-tuberculosis-and-vitamin-d">Overview Tuberculosis and Vitamin D&lt;/a>&lt;/p></description></item><item><title>Children with active TB were 4.6X more likely to have low vitamin D</title><link>/posts/children-with-active-tb-were-46x-more-likely-to-have-low-vitamin-d.html</link><pubDate>Fri, 12 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/children-with-active-tb-were-46x-more-likely-to-have-low-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-and-tuberculosis-a-multicenter-study-in-children">Vitamin D and tuberculosis: a multicenter study in children&lt;/h3>
&lt;p>BMC Infectious Diseases 2014, 14:652 doi:10.1186/s12879-014-0652-7&lt;/p>
&lt;p>Elisabetta Venturini 1, Ludovica Facchini 1, Nuria Martinez-Alier 2, Vas Novelli 3, Luisa Galli 1,&lt;/p>
&lt;p>Maurizio de Martino 1 &lt;a href="mailto:maurizio.demartino@unifi.it">maurizio.demartino@unifi.it&lt;/a> and Elena Chiappini 1&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/tb-1.jpg" alt="image" width="400">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/tb-and-vitamin-d.jpg" alt="image" width="400">
&lt;p>Background The aim of this study is to evaluate vitamin D levels in children with latent and active TB compared to healthy controls of the same age and ethnical background.&lt;/p>
&lt;p>Methods A multicenter observational study has been conducted in three tertiary care paediatric centres: Anna Meyer Children&amp;rsquo;s University Hospital, Florence, Italy; Evelina London Children&amp;rsquo;s Hospital, London, United Kingdom and Great Ormond Street Hospital, London, United Kingdom. Vitamin D was considered deficient if the serum level was &amp;lt;25?nmol/L, insufficient between 25 and 50?nmol/L and sufficient for a level &amp;gt;50?nmol/L.&lt;/p></description></item><item><title>Less likely to catch Tuberculosis if have OK level of vitamin D</title><link>/posts/less-likely-to-catch-tuberculosis-if-have-ok-level-of-vitamin-d.html</link><pubDate>Sat, 29 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/less-likely-to-catch-tuberculosis-if-have-ok-level-of-vitamin-d.html</guid><description/></item><item><title>The Antibiotic Effects of Vitamin D – 2014</title><link>/posts/the-antibiotic-effects-of-vitamin-d-2014.html</link><pubDate>Mon, 24 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/the-antibiotic-effects-of-vitamin-d-2014.html</guid><description>&lt;p>Endocrine, Metabolic &amp;amp; Immune Disorders-Drug Targets Vol 14, issue 4, Pages 255-266 (12)&lt;/p>
&lt;p>Chunxiao Guo and Adrian F. Gombart&lt;/p>
&lt;p>Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, 307 Linus Pauling Science Center, Corvallis, OR 97331, USA.&lt;/p>
&lt;p>The recent discovery that vitamin D regulates expression of the cathelicidin antimicrobial peptide gene has generated renewed interest in using vitamin D to fight infectious diseases. This review describes the historical use of vitamin D or its sources to treat infections, the mechanism of action through which vitamin D mediates its “antibiotic” effects, findings from epidemiological studies associating vitamin D deficiency with increased susceptibility to infection and clinical trials with vitamin D supplementation to treat or prevent infections. Furthermore studies examining an association between vitamin D levels and cathelicidin expression are discussed. The role of cathelcidin throughout the course of infection from the initial encounter of the pathogen to the resolution of tissue damage and inflammation indicates that individuals need to maintain adequate levels of vitamin D for an optimal immune response. In addition, for treating infections, carefully designed randomized, clinical trials that are appropriately powered to detect modest effects, target populations that are severely deficient in vitamin D, and optimized dose, dosing frequency and safety are needed.&lt;/p></description></item><item><title>Vitamin D and infectious diseases like RTI, TB and Sepsis</title><link>/posts/vitamin-d-and-infectious-diseases-like-rti-tb-and-sepsis.html</link><pubDate>Mon, 24 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-infectious-diseases-like-rti-tb-and-sepsis.html</guid><description>&lt;h3 id="vitamin-d-and-infectious-diseases">Vitamin d and infectious diseases.&lt;/h3>
&lt;p>Endocr Metab Immune Disord Drug Targets. 2014;14(4):267-71.&lt;/p>
&lt;p>Miragliotta G, Miragliotta L1.&lt;/p>
&lt;p>In the early 1920s the antirachitic effect of food irradiated with ultraviolet light and cod liver oil has been recognized. The antirachitic substance was identified and called &amp;ldquo;vitamin D&amp;rdquo;. Since then the key role of vitamin D in calcium and bone homeostasis has been investigated. Moreover, it has been recognized that vitamin D is able to modulate a variety of processes and regulatory systems such as host defense, inflammation, immunity, and repair. According to recent studies, vitamin D deficiency is likely to be an important etiological factor in the pathogenesis of many chronic diseases, as well as it has been associated with higher mortality rate for respiratory disease. In this regard, either observational studies aimed to verify an association between low vitamin D level and the incidence of respiratory tract infections (RTIs) or clinical trials on the effect of vitamin D as a supplementary treatment in RTIs patients have been presented in the emerging clinical literature. Conflicting results have been demonstrated in several randomized, doubleblind, placebo controlled trials concerning the vitamin D treatment in tuberculosis. Some studies suggest a beneficial effect by vitamin D but it could not be reproduced in larger studies so far. In conclusion, although basic science research suggests that vitamin D may play an important role in modulating immune functions, no strong evidence exists whether correction of vitamin D depletion may be useful in the prevention or treatment of infections. Further and larger studies may clarify the role of vitamin D in infection.&lt;/p></description></item><item><title>Tuberculosis risk decreased by 6 percent for each 1 ng increase in Vitamin D</title><link>/posts/tuberculosis-risk-decreased-by-6-percent-for-each-1-ng-increase-in-vitamin-d.html</link><pubDate>Sun, 12 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-risk-decreased-by-6-percent-for-each-1-ng-increase-in-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-status-and-incidence-of-tuberculosis-infection-conversion-in-contacts-of-pulmonary-tuberculosis-patients-a-prospective-cohort-study">Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: a prospective cohort study.&lt;/h4>
&lt;p>Epidemiol Infect. 2014 Oct 2:1-11. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Arnedo-Pena A1, Juan-Cerdán JV2, Romeu-García MA1, García-Ferrer D2, Holguín-Gómez R3, Iborra-Millet J2, Pardo-Serrano F4.&lt;/p>
&lt;p>SUMMARY&lt;/p>
&lt;p>The objective of this study was to estimate the relationship between serum vitamin D (VitD) status and tuberculosis (TB) infection conversion (TBIC), measured by the tuberculin skin test (TST) and an interferon-gamma release assay, the QuantiFERON-TB Gold In-Tube (QFT-GIT) test, in the contacts of pulmonary TB patients in Castellon (Spain) in a prospective cohort study from 2010 to 2012. Initially, the participants were negative to latent TB infection after a screening that included TST and QFT-GIT tests, and other examinations. A baseline determination of 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> was obtained by chemiluminescence immunoassay. After 8-10 weeks, participants were screened for a second time to determine TB infection conversion (TBIC). Poisson regression models were used in the statistical analysis. Of the 247 participants in the cohort, 198 (80·2%) were screened twice and 18 (9·1%) were TBIC cases. The means of VitD concentration in the TBIC cases and the non-cases were 20·7±11·9 and 27·2±11·4 ng/ml (P = 0·028), respectively. Adjusted for high exposure and TB sputum acid-fast bacilli (AFB)-positive index case, higher serum VitD concentration was associated with low incidence of TBIC (P trend = 0·005), and an increase of 1 ng/ml VitD concentration decreased the incidence of TBIC by 6% (relative risk 0·94, 95% confidence interval 0·90-0·99, P = 0·015). The results suggest that sufficient VitD level could be a protective factor of TBIC.&lt;/p></description></item><item><title>Tuberculosis is controlled by Interleukin-32 when it has enough Vitamin D – patent applied for</title><link>/posts/tuberculosis-is-controlled-by-interleukin-32-when-it-has-enough-vitamin-d-patent-applied-for.html</link><pubDate>Fri, 22 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-is-controlled-by-interleukin-32-when-it-has-enough-vitamin-d-patent-applied-for.html</guid><description>&lt;h3 id="new-interaction-discovered-between-vitamin-d-and-certain-protein-in-tuberculosishttpwwwvitamindcouncilorgvitamin-d-newsnew-interaction-discovered-between-vitamin-d-and-certain-protein-in-tuberculosis-vitamin-d-council-describes-the-study">&lt;a href="http://www.vitamindcouncil.org/vitamin-d-news/new-interaction-discovered-between-vitamin-d-and-certain-protein-in-tuberculosis/#">New interaction discovered between vitamin D and certain protein in tuberculosis&lt;/a> Vitamin D Council describes the study&lt;/h3>
&lt;h3 id="study-identifies-protein-that-helps-prevent-active-tuberculosis-in-infected-patientshttpnewsroomuclaedureleasesstudy-identifies-protein-that-helps-prevent-active-tuberculosis-in-infected-patients-ucla-newsroom">&lt;a href="http://newsroom.ucla.edu/releases/study-identifies-protein-that-helps-prevent-active-tuberculosis-in-infected-patients">Study identifies protein that helps prevent active tuberculosis in infected patients&lt;/a> UCLA Newsroom&lt;/h3>
&lt;ul>
&lt;li>
&lt;p>“When vitamin D levels were low, IL-32 was not able to kill the bacteria,”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>. . applied for a patent application for further development of IL-32 as a potential diagnostic marker to see which patients with latent TB are at risk for activation of the disease, as well as for use as a possible therapeutic to treat tuberculosis by stimulating antimicrobial activity.&lt;/p></description></item><item><title>Tuberculosis, Genes, Vitamin D Binding Protein, and RCT – Review</title><link>/posts/tuberculosis-genes-vitamin-d-binding-protein-and-rct-review.html</link><pubDate>Mon, 18 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-genes-vitamin-d-binding-protein-and-rct-review.html</guid><description>&lt;h4 id="vitamin-d-status-receptor-gene-polymorphisms-and-supplementation-on-tuberculosis">Vitamin D Status, Receptor Gene Polymorphisms, and Supplementation on Tuberculosis:&lt;/h4>
&lt;p>A Systematic Review of Case-Control Studies and Randomized Controlled Trials&lt;/p>
&lt;p>Journal of Clinical &amp;amp; Translational Endocrinology, DOI: &lt;a href="http://dx.doi.org/10.1016/j.jcte.2014.08.001">http://dx.doi.org/10.1016/j.jcte.2014.08.001&lt;/a>&lt;/p>
&lt;p>Nilay Sutariaemail, Ching-Ti Liuemail, Tai C. Chenemail&lt;/p>
&lt;p>Received: May 23, 2014; Received in revised form: July 25, 2014; Accepted: August 7, 2014; Published Online: August 15, 2014&lt;/p>
&lt;h3 id="highlights">Highlights:&lt;/h3>
&lt;p>•Lower serum 25-hydroxyvitamin D increases susceptibility to tuberculosis.&lt;/p>
&lt;p>•BsmI and FokI VDR gene polymorphisms may confer increased risk of acquiring tuberculosis.&lt;/p></description></item><item><title>Tuberculosis, genes and vitamin D – Meta-Analysis</title><link>/posts/tuberculosis-genes-and-vitamin-d-meta-analysis.html</link><pubDate>Wed, 18 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-genes-and-vitamin-d-meta-analysis.html</guid><description>&lt;h3 id="vitamin-d-receptor-gene-polymorphisms-on-the-risk-of-tuberculosis-a-meta-analysis-of-29-case-control-studies">Vitamin D Receptor Gene Polymorphisms on the Risk of Tuberculosis, a Meta-Analysis of 29 Case-Control Studies&lt;/h3>
&lt;p>PLOS ONE Published: December 13, 2013, DOI: 10.1371/journal.pone.0083843&lt;/p>
&lt;p>Cheng Chen, Qiao Liu, Limei Zhu, Haitao Yang, Wei Lu mail&lt;/p>
&lt;p>The relationship of four potentially functional polymorphisms of the vitamin D receptor (VDR) gene, ApaI, BsmI, FokI and TaqI , with tuberculosis susceptibility were considered. The aim of this meta-analysis was to explore the association between the four polymorphisms and tuberculosis risk in different ethnic backgrounds. Eligible case-control studies that were catalogued before April 1st 2013 were enrolled, and the heterogeneity between the studies was evaluated using a χ2 based Q-test. Fixed and random effect models were built to evaluate the association of the four polymorphisms with the risk of tuberculosis, and the association between the four polymorphisms and tuberculosis was expressed as the odds ratio (OR) and 95% confidence interval (CI).&lt;/p></description></item><item><title>Wondering about tuberculosis and Vitamin D in Australia</title><link>/posts/wondering-about-tuberculosis-and-vitamin-d-in-australia.html</link><pubDate>Sun, 17 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/wondering-about-tuberculosis-and-vitamin-d-in-australia.html</guid><description>&lt;h4 id="vitamin-d-and-vitamin-d-and-tuberculosis-hope-or-hype">Vitamin D and Vitamin D and tuberculosis: hope or hype?&lt;/h4>
&lt;p>Med J Aust 2013; 199 (10): 648-649. Doi: 10.5694/mja13.11174&lt;/p>
&lt;p>Anna P Ralph, MPH, FRACP, PhD, Clinical Research Fellow1&lt;/p>
&lt;p>Robyn M Lucas, MB ChB, PhD, FAFPHM, Associate Professor2&lt;/p>
&lt;p>1 Global and Tropical Health, Menzies School of Health Research, Darwin, NT.&lt;/p>
&lt;p>2 National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT.&lt;/p>
&lt;p>&lt;strong>It may be worthwhile to test for and treat vitamin D deficiency in latent infection, but not in active TB&lt;/strong>&lt;/p></description></item><item><title>Tuberculosis associated with vitamin D deficiency</title><link>/posts/tuberculosis-associated-with-vitamin-d-deficiency.html</link><pubDate>Sat, 02 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-associated-with-vitamin-d-deficiency.html</guid><description>&lt;h2 id="vitamin-d-deficiency-in-patients-with-tuberculosis">Vitamin d deficiency in patients with tuberculosis.&lt;/h2>
&lt;p>J Coll Physicians Surg Pak. 2013 Nov;23(10):780-3. &lt;a href="https://doi.org/11.2013/JCPSP.780783.">doi: 11.2013/JCPSP.780783.&lt;/a>&lt;/p>
&lt;p>Iftikhar R, Kamran SM, Qadir A, Haider E, Hassan Bin Usman.&lt;/p>
&lt;p>Department of Medicine, Combined Military Hospital, Kharian.&lt;/p>
&lt;p>Objective: To determine the frequency and association of Vitamin D deficiency in patients with tuberculosis. Study&lt;/p>
&lt;p>Design: Case control study. Place and Duration of Study: Medical Department, Combined Military Hospital, Kharian, from July 2010 to June 2012.&lt;/p></description></item><item><title>Increase immunity to TB-like bacteria if visit high altitude</title><link>/posts/increase-immunity-to-tb-like-bacteria-if-visit-high-altitude.html</link><pubDate>Sun, 15 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/increase-immunity-to-tb-like-bacteria-if-visit-high-altitude.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#effects-of-ascent-to-high-altitude-on-human-antimycobacterial-immunity">Effects of Ascent to High Altitude on Human Antimycobacterial Immunity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#better-resistance-to-tb-like-bacteria--about-half-a-day-after-getting-to-high-altitude">Better resistance to TB-like bacteria about half a day after getting to high altitude&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="effects-of-ascent-to-high-altitude-on-human-antimycobacterial-immunity">Effects of Ascent to High Altitude on Human Antimycobacterial Immunity&lt;/h4>
&lt;p>PLOS ONE&lt;/p>
&lt;p>Sarah Eisen equal contributor, Louise Pealing equal contributor, Robert W. Aldridge,&lt;/p>
&lt;p>Mark J. Siedner, Alejandro Necochea, Inna Leybell, Teresa Valencia, Beatriz Herrera,&lt;/p>
&lt;p>Siouxsie Wiles, Jon S. Friedland, Robert H. Gilman, Carlton A. Evans mail&lt;/p></description></item><item><title>Tuberculosis, UV and perhaps vitamin D</title><link>/posts/tuberculosis-uv-and-perhaps-vitamin-d.html</link><pubDate>Mon, 22 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-uv-and-perhaps-vitamin-d.html</guid><description>&lt;h1 class="svTitle">
&lt;p>&lt;span style="font-size:22px;">Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis&lt;/span>&lt;/h1>&lt;/p>
&lt;div class="publicationHead titleBanner">
&lt;div class="cover">
&lt;div class="title">
&lt;p>&lt;a class="cLink" href="http://www.sciencedirect.com/science/journal/14733099" title="Go to The Lancet Infectious Diseases on SciVerse ScienceDirect">&lt;img alt="The Lancet Infectious Diseases" class="imgLazyJSB" height="25" src="http://ars.els-cdn.com/content/image/B14733099.gif" width="310" />&lt;/a>&lt;a href="http://www.sciencedirect.com/science/journal/14733099/13/1" title="Go to table of contents for this volume/issue">Volume 13, Issue 1&lt;/a>, January 2013, Pages 77–88&lt;/div>&lt;/p>
&lt;/div>
&lt;/div>
&lt;ul class="authorGroup noCollab">&lt;li>
&lt;p>&lt;span class="authorDegrees">Dr &lt;/span>&lt;a class="authorName" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#" id="authname_N5d0e3940N5d020df8">Anna P Ralph&lt;/a>, &lt;span class="authorDegrees">PhD&lt;/span>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff1" id="baff1" title="Affiliation: a">&lt;sup>a&lt;/sup>&lt;/a>&lt;sup>, &lt;/sup>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff2" id="baff2" title="Affiliation: b">&lt;sup>b&lt;/sup>&lt;/a>&lt;sup>, &lt;/sup>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff3" id="baff3" title="Affiliation: c">&lt;sup>c&lt;/sup>&lt;/a>&lt;sup>, &lt;/sup>&lt;a class="intra_ref auth_corr" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#cor1" id="bcor1" title="Corresponding author contact information">&lt;img alt="Corresponding author contact information" class="imgLazyJSB" src="http://cdn.els-cdn.com/sd/entities/REcor.gif" />&lt;/a>&lt;sup>, &lt;/sup>&lt;a href="mailto:anna.ralph@menzies.edu.au">anna.ralph@menzies.edu.au&lt;/a>&lt;/li>&lt;/p>
&lt;li>
&lt;p>&lt;a class="authorName" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#" id="authname_N5d0e3940N5d020ee8">Robyn M Lucas&lt;/a>, &lt;span class="authorDegrees">PhD&lt;/span>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff4" id="baff4" title="Affiliation: d">&lt;sup>d&lt;/sup>&lt;/a>,&lt;/li>&lt;/p></description></item><item><title>Tuberculosis, ethnic differences, and vitamin D</title><link>/posts/tuberculosis-ethnic-differences-and-vitamin-d.html</link><pubDate>Fri, 05 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-ethnic-differences-and-vitamin-d.html</guid><description>&lt;h2 id="ethnic-differences-affect-immune-response-to-tuberculosis-infection">Ethnic Differences Affect Immune Response To Tuberculosis Infection&lt;/h2>
&lt;p>^Comment by VitaminDWiki&lt;/p>
&lt;p>Does not appear to mention the lower vitamin D levels in those with dark skins^&lt;/p>
&lt;p>&lt;strong>&lt;a href="http://trap.it/#!traps/id/907cd246-0855-49f4-97b4-04aaff5e62f3/articles/6HsUm3uJq0064crtMTSu%20">AsianScientist (Jul. 5, 2013) – Health &amp;amp; Medicine&lt;/a>&lt;/strong>&lt;/p>
&lt;p>The immune response to the bacterium that causes tuberculosis (TB) varies between patients of different ethnic origin, according to a new UK study.&lt;/p>
&lt;p>The study, published in the journal PLOS Pathogens and led by researchers at Queen Mary, University of London, analyzed the immune response of 128 newly-diagnosed TB patients in London who were divided by ethnicity into those of African (45), European (27), Asian (55) or mixed European/Asian (1) ancestry.&lt;/p></description></item><item><title>Tuberculosis varies with UVB in Australia</title><link>/posts/tuberculosis-varies-with-uvb-in-australia.html</link><pubDate>Tue, 19 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-varies-with-uvb-in-australia.html</guid><description>&lt;h2 id="link-between-vitamin-d-levels-and-developing-tuberculosishttpwwwscoopconzstoriesge1303s00078link-between-vitamin-d-levels-and-developing-tuberculosishtm">&lt;a href="http://www.scoop.co.nz/stories/GE1303/S00078/link-between-vitamin-d-levels-and-developing-tuberculosis.htm">Link between vitamin D levels and developing tuberculosis&lt;/a>&lt;/h2>
&lt;h4 id="press-release-by-australasian-society-for-infectious-diseases">Press Release by Australasian Society for Infectious Diseases&lt;/h4>
&lt;p>New research presented at this week’s Annual Scientific Meeting of the Australasian Society for Infectious Diseases (ASID) in Canberra, Australia, suggests a link between vitamin D levels and the risk of developing tuberculosis (TB), with rates of &lt;strong>TB incidence up to 37% higher following darker winter months&lt;/strong> than during the rest of the year. The research is by Jennifer MacLachlan, Victorian Infectious Diseases Reference Laboratory, Melbourne, and University of Melbourne, VIC, Australia, and Dr Benjamin Cowie (the same affiliations plus the Royal Melbourne Hospital, VIC, Australia).&lt;/p></description></item><item><title>Vitamin D increasingly associated with inflammation such as RA, TB, Lupus, and cancer</title><link>/posts/vitamin-d-increasingly-associated-with-inflammation-such-as-ra-tb-lupus-and-cancer.html</link><pubDate>Mon, 25 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-increasingly-associated-with-inflammation-such-as-ra-tb-lupus-and-cancer.html</guid><description>&lt;h3 id="there-are-two-articles-on-this-page">There are two articles on this page&lt;/h3>
&lt;hr>
&lt;h3 id="an-update-vitamin-d-deficiency-and-risk-for-rheumatic-diseases">An Update: Vitamin D Deficiency and Risk for Rheumatic Diseases&lt;/h3>
&lt;p>Paul Gatenby, Robyn Lucas, Ashwin Swaminathan&lt;/p>
&lt;p>Curr Opin Rheumatol. 2013;25(2):184-191.&lt;/p>
&lt;h4 id="diseases-include">Diseases include&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Lupus&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Rheumatoid Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Juvenile Idiopathic Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Systemic Vasculitis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Psoriatic Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Scleroderma&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Behcet&amp;rsquo;s Disease&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Spondyloarthropathies&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Connective Tissue Disease&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>&lt;strong>PDF is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;hr>
&lt;h3 id="further-emergent-evidence-for-the-vitamin-d-endocrine-system-involvement-in-autoimmune-rheumatic-disease-risk-and-prognosis">Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis&lt;/h3>
&lt;p>&lt;strong>Annals of Rheumatic Diseases EDITORIAL&lt;/strong> , April 2013 Vol 72 No 4&lt;/p></description></item><item><title>Every TB patient benefited from 2 doses of 600,000 IU of vitamin D – RCT</title><link>/posts/every-tb-patient-benefited-from-2-doses-of-600000-iu-of-vitamin-d-rct.html</link><pubDate>Sat, 19 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/every-tb-patient-benefited-from-2-doses-of-600000-iu-of-vitamin-d-rct.html</guid><description>&lt;h4 id="vitamin-d-accelerates-clinical-recovery-from-tuberculosis-results-of-the-succinct-study-spansupplementary-cholecalciferol-in-recovery-from-tuberculosisspan-a-randomized-placebo-controlled-clinical-trial-of-vitamin-d-supplementation-in-patients-with-pulmonary-tuberculosis">Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study &lt;span>[Supplementary Cholecalciferol in recovery from tuberculosis]&lt;/span>. A randomized, placebo-controlled, clinical trial of vitamin d supplementation in patients with pulmonary tuberculosis'&lt;/h4>
&lt;p>BMC Infectious Diseases 2013, 13:22 doi:10.1186/1471-2334-13-22&lt;/p>
&lt;p>Nawal Salahuddin, Farheen Ali, Zahra Hasan, Nisar Rao, Masooma Aqeel and Faisal Mahmood&lt;/p>
&lt;p>Published: 19 January 2013&lt;/p>
&lt;p>Background&lt;/p>
&lt;p>Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculosis (TB) could influence recovery.&lt;/p></description></item><item><title>Childhood TB prevention and treatment by vitamin D looks promising – 2012</title><link>/posts/childhood-tb-prevention-and-treatment-by-vitamin-d-looks-promising-2012.html</link><pubDate>Wed, 02 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/childhood-tb-prevention-and-treatment-by-vitamin-d-looks-promising-2012.html</guid><description/></item><item><title>Higher rates of TB in Winter and further from Equator</title><link>/posts/higher-rates-of-tb-in-winter-and-further-from-equator.html</link><pubDate>Thu, 01 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/higher-rates-of-tb-in-winter-and-further-from-equator.html</guid><description/></item><item><title>Vitamin D probably can prevent and treat TB and infectious diseases – 2012</title><link>/posts/vitamin-d-probably-can-prevent-and-treat-tb-and-infectious-diseases-2012.html</link><pubDate>Sun, 30 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-probably-can-prevent-and-treat-tb-and-infectious-diseases-2012.html</guid><description/></item><item><title>Multidrug-resistant tuberculosis may be reduced with vitamin D</title><link>/posts/multidrug-resistant-tuberculosis-may-be-reduced-with-vitamin-d.html</link><pubDate>Thu, 20 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/multidrug-resistant-tuberculosis-may-be-reduced-with-vitamin-d.html</guid><description/></item><item><title>TB treatment helped with Vitamin D – RCT</title><link>/posts/tb-treatment-helped-with-vitamin-d-rct.html</link><pubDate>Wed, 19 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/tb-treatment-helped-with-vitamin-d-rct.html</guid><description/></item><item><title>TB vaccinations increased vitamin D levels a year later</title><link>/posts/tb-vaccinations-increased-vitamin-d-levels-a-year-later.html</link><pubDate>Wed, 01 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/tb-vaccinations-increased-vitamin-d-levels-a-year-later.html</guid><description>&lt;h4 id="bcg-vaccination-a-role-for-vitamin-d">BCG Vaccination: A Role for Vitamin D?&lt;/h4>
&lt;p>PLoS One. 2011; 6(1): e16709.&lt;/p>
&lt;p>Published online 2011 January 31. &lt;a href="https://doi.org/10.1371/journal.pone.0016709">doi: 10.1371/journal.pone.0016709&lt;/a>&lt;/p>
&lt;p>Maeve K. Lalor,1,* Sian Floyd,2 Patricia Gorak-Stolinska,1 Rosemary E. Weir,1 Rose Blitz,1 Keith Branson,2 Paul E. Fine,2 and Hazel M. Dockrell1&lt;/p>
&lt;p>Background: BCG vaccination is administered in infancy in most countries with the aim of providing &lt;strong>protection against tuberculosis&lt;/strong> . There is increasing interest in the role of vitamin D in immunity to tuberculosis. This study objective was to determine if there was an association between circulating 25(OH)D concentrations and BCG vaccination status and cytokine responses following BCG vaccination in infants.&lt;/p></description></item><item><title>Probability of getting TB reduced 60 percent with just 800 IU of vitamin D – RCT</title><link>/posts/probability-of-getting-tb-reduced-60-percent-with-just-800-iu-of-vitamin-d-rct.html</link><pubDate>Wed, 04 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/probability-of-getting-tb-reduced-60-percent-with-just-800-iu-of-vitamin-d-rct.html</guid><description/></item><item><title>Patients having both Diabetes and TB treated by vitamin D</title><link>/posts/patients-having-both-diabetes-and-tb-treated-by-vitamin-d.html</link><pubDate>Wed, 20 Jun 2012 00:00:00 +0000</pubDate><guid>/posts/patients-having-both-diabetes-and-tb-treated-by-vitamin-d.html</guid><description>&lt;h4 id="response-to-vitamin-d-supplementation-in-type-2-diabetes-patients-with-pulmonary-tuberculosis">Response to Vitamin D Supplementation in Type 2 Diabetes Patients with Pulmonary Tuberculosis&lt;/h4>
&lt;p>Endocr Rev, Vol. 33 (03_MeetingAbstracts): SAT-168&lt;/p>
&lt;p>Copyright © 2012 by The Endocrine Society ENDO 2012: June 23-26, 2012, Houston, Texas&lt;/p>
&lt;p>Sunil K Kota, MD1, Siva K Kota, MD, DNB2, Svs Krishna, MD1, Lalit K Meher, MD3 and Kirtikumar D Modi, DM, DNB1&lt;/p>
&lt;p>1 Endocrinology, Medwin Hospital Hyderabad, India&lt;/p>
&lt;p>2 Anesthesia, Central Security Hospital Riyadh, Saudi Arabia&lt;/p>
&lt;p>3 Medicine, MKCG Medical College Berhampur, India&lt;/p></description></item><item><title>Vitamin D and the Lung – professional book 2012</title><link>/posts/vitamin-d-and-the-lung-professional-book-2012.html</link><pubDate>Sun, 27 May 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-the-lung-professional-book-2012.html</guid><description/></item><item><title>79 percent of TB in East London less 20 ng vitamin D</title><link>/posts/79-percent-of-tb-in-east-london-less-20-ng-vitamin-d.html</link><pubDate>Fri, 04 May 2012 00:00:00 +0000</pubDate><guid>/posts/79-percent-of-tb-in-east-london-less-20-ng-vitamin-d.html</guid><description>&lt;h2 id="span-stylecolor00fpdf-is-attached-at-bottom-of-this-pagespan">&lt;strong>&lt;span style="color:#00F;">PDF is attached at bottom of this page&lt;/span>&lt;/strong>&lt;/h2></description></item><item><title>Vitamin D testing typically not needed, but in 9 cases it is</title><link>/posts/vitamin-d-testing-typically-not-needed-but-in-9-cases-it-is.html</link><pubDate>Fri, 04 May 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-testing-typically-not-needed-but-in-9-cases-it-is.html</guid><description>&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>&lt;a href="/posts/many-ways-to-get-2x-increased-response-from-the-same-dose" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 1918">Many ways to get 2X increased response from the same dose&lt;/a>&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>this study does not appear to have tried any of the ways - such as use of co-factors like Magnesium, Vitamin K2, etc.&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>
&lt;p>This study does not seem to consider use of &lt;a href="/posts/loading-bolusstoss-doses" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 326">loading /bolus/Stoss doses&lt;/a>, only maintenance doses&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/no-vitamin-d-test-needed-before-supplementing-typically">No vitamin D test needed before supplementing (typically) – April 2014&lt;/a>&lt;/p></description></item><item><title>TB worst in March, lowest vitamin D – CDC</title><link>/posts/tb-worst-in-march-lowest-vitamin-d-cdc.html</link><pubDate>Sat, 07 Apr 2012 00:00:00 +0000</pubDate><guid>/posts/tb-worst-in-march-lowest-vitamin-d-cdc.html</guid><description>&lt;h4 id="seasonality-of-tuberculosis-in-the-united-states-19932008">Seasonality of Tuberculosis in the United States, 1993–2008&lt;/h4>
&lt;p>Matthew D. Willis 1, Carla A. Winston 2, Charles M. Heilig 2, Kevin P. Cain 2, Nicholas D. Walter 3, and William R. Mac Kenzie 2&lt;/p>
&lt;p>1 Epidemic Intelligence Service Program&lt;/p>
&lt;p>2 Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia&lt;/p>
&lt;p>3 Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora&lt;/p>
&lt;p>Correspondence: Matthew D. Willis, MD, MPH, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS E-10, Atlanta, GA 30333 (&lt;a href="mailto:mwillis@cdc.gov">mwillis@cdc.gov&lt;/a>).&lt;/p></description></item><item><title>Review of infectious diseases vitamin D trials</title><link>/posts/review-of-infectious-diseases-vitamin-d-trials.html</link><pubDate>Mon, 13 Feb 2012 00:00:00 +0000</pubDate><guid>/posts/review-of-infectious-diseases-vitamin-d-trials.html</guid><description/></item><item><title>Lung and Vitamin D – Special Issue</title><link>/posts/lung-and-vitamin-d-special-issue.html</link><pubDate>Sat, 31 Dec 2011 00:00:00 +0000</pubDate><guid>/posts/lung-and-vitamin-d-special-issue.html</guid><description/></item><item><title>TB 10X less likely to catch if have sufficient vitamin D</title><link>/posts/tb-10x-less-likely-to-catch-if-have-sufficient-vitamin-d.html</link><pubDate>Fri, 16 Dec 2011 00:00:00 +0000</pubDate><guid>/posts/tb-10x-less-likely-to-catch-if-have-sufficient-vitamin-d.html</guid><description>&lt;h4 id="latent-tuberculosis-infectiontuberculin-skin-test-conversion-and-vitamin-d-status-in-contacts-of-tuberculosis-patients-a-cross-sectional-and-case-control-study">Latent tuberculosis infection,tuberculin skin test conversion and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study.&lt;/h4>
&lt;p>Alberto Arnedo-Pena, Jose V Juan-Cerdan, Angeles Romeu-Gracia, Daniel Garcia-Ferrer, Rita Holguin-Gomez, Jesus Iborra-Millet, Concepcion Herrero-Carot, Jesus Sanchis-Pinana, Juan Bellido-Blasco, Jose A Ferrero-Vega, Lourdes S Adsuara, Esther S Silvestre, Noemi M Ferrer and Vicenta R Bartual&lt;/p>
&lt;p>BMC Infectious Diseases 2011, 11:349 doi:10.1186/1471-2334-11-349; Published: 15 December 2011&lt;/p>
&lt;p>Background Deficient serum vitamin D levels have been associated with incidence of tuberculosis (TB), and latent tuberculosis infection (LTBI). However, to our knowledge, no studies on vitamin D status and tuberculin skin test (TST) conversion have been published to date. The aim of this study was to estimate the associations of serum 25-hydroxyvitamin D3 (25&lt;span>[OH]&lt;/span>D) status with LTBI prevalence and TST conversion in contacts of active TB in Castellon (Spain).&lt;/p></description></item><item><title>Big impact of Vitamin D in the Treatment of Tuberculosis</title><link>/posts/big-impact-of-vitamin-d-in-the-treatment-of-tuberculosis.html</link><pubDate>Wed, 24 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/big-impact-of-vitamin-d-in-the-treatment-of-tuberculosis.html</guid><description>&lt;h1 id="impact-of-vitamin-d-in-the-treatment-of-tuberculosis">Impact of Vitamin D in the Treatment of Tuberculosis&lt;/h1>
&lt;p>American Journal of the Medical Sciences: Review Article&lt;/p>
&lt;p>June 2011 - Volume 341 - Issue 6 - pp 493-498&lt;/p>
&lt;p>&lt;a href="https://doi.org/10.1097/MAJ.0b013e3182070f47">doi: 10.1097/MAJ.0b013e3182070f47&lt;/a>&lt;/p>
&lt;p>Luong, Khanh vinh quoc MD; Nguyen, Lan Thi Hoang MD&lt;/p>
&lt;p>From the Vietnamese American Research Foundation, Westminster, California.&lt;/p>
&lt;p>Submitted July 20, 2010; accepted in revised form November 12, 2010.&lt;/p>
&lt;p>Correspondence: Khanh vinh quoc Luong, MD, 14971 Brookhurst Street, Westminster, CA 92683 (E-mail: &lt;a href="mailto:Lng2687765@aol.com">Lng2687765@aol.com&lt;/a>).&lt;/p></description></item><item><title>Vitamin D patent for treating immune system diseases</title><link>/posts/vitamin-d-patent-for-treating-immune-system-diseases.html</link><pubDate>Sun, 03 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-patent-for-treating-immune-system-diseases.html</guid><description>&lt;h2 id="wo2008039409httpwwwwipointpatentscopesearchenwo2008039409-world-wide-patent---2008">&lt;a href="http://www.wipo.int/patentscope/search/en/WO2008039409">(WO2008039409)&lt;/a> World-Wide patent - 2008&lt;/h2>
&lt;h4 id="treatment-and-prevention-of-diseases-or-conditions-of-the--immune-system-or-infectious-diseases">TREATMENT AND PREVENTION OF DISEASES OR CONDITIONS OF THE &lt;strong>IMMUNE SYSTEM OR INFECTIOUS DISEASES&lt;/strong>&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>allergic rhinitis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>eczema,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>psoriasis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>food allergy,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>type-1 diabetes,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>ulcerative colitis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Crohn&amp;rsquo;s disease,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>rheumatoid arthritis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>multiple sclerosis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>lupus,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>tuberculosis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>parasitic infection, etc,&lt;/p>
&lt;/li>
&lt;/ul></description></item><item><title>TB vaccinations greatly increased vitamin D</title><link>/posts/tb-vaccinations-greatly-increased-vitamin-d.html</link><pubDate>Sat, 02 Apr 2011 00:00:00 +0000</pubDate><guid>/posts/tb-vaccinations-greatly-increased-vitamin-d.html</guid><description>&lt;h3 id="bcg-vaccination-a-role-for-vitamin-d">BCG Vaccination: A Role for Vitamin D?&lt;/h3>
&lt;p>PLoS One. 2011; 6(1): e16709. Published online 2011 January 31. &lt;a href="https://doi.org/10.1371/journal.pone.0016709.">doi: 10.1371/journal.pone.0016709.&lt;/a>&lt;/p>
&lt;p>Maeve K. Lalor,1* Sian Floyd,2 Patricia Gorak-Stolinska,1 Rosemary E. Weir,1 Rose Blitz,1 Keith Branson,2 Paul E. Fine,2 and Hazel M. Dockrell1&lt;/p>
&lt;p>1Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene &amp;amp; Tropical Medicine, London, United Kingdom&lt;/p>
&lt;p>2Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene &amp;amp; Tropical Medicine, London, United Kingdom&lt;/p></description></item><item><title>People with TB and one geneotype benefited more from 10000 IU of vitamin D</title><link>/posts/people-with-tb-and-one-geneotype-benefited-more-from-10000-iu-of-vitamin-d.html</link><pubDate>Mon, 21 Feb 2011 00:00:00 +0000</pubDate><guid>/posts/people-with-tb-and-one-geneotype-benefited-more-from-10000-iu-of-vitamin-d.html</guid><description>&lt;h1 id="high-dose-vitamin-d3-during-intensive-phase-antimicrobial-treatment-of-pulmonary-tuberculosis-a-double-blind-randomised-controlled-trial">High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.&lt;/h1>
&lt;p>Lancet. 2011 Jan 15;377(9761):242-50. Epub 2011 Jan 5.&lt;/p>
&lt;p>Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Woodward NJ, Venton TR, Barnes KE, Mullett CJ, Coussens AK, Rutterford CM, Mein CA, Davies GR, Wilkinson RJ, Nikolayevskyy V, Drobniewski FA, Eldridge SM, Griffiths CJ.&lt;/p></description></item><item><title>Overview Tuberculosis and Vitamin D</title><link>/posts/overview-tuberculosis-and-vitamin-d.html</link><pubDate>Sat, 19 Feb 2011 00:00:00 +0000</pubDate><guid>/posts/overview-tuberculosis-and-vitamin-d.html</guid><description>&lt;h4 id="tb-treated-by-sunlight-then-cod-liver-oil--vitamin-d-then-antibiotics-but-tb-is-becoming-resistant">TB treated by Sunlight, then cod liver oil &amp;amp; Vitamin D, then antibiotics (but TB is becoming resistant)&amp;hellip;&lt;/h4>
&lt;p>&lt;strong>Dec 2023: ChatGPT-4 was asked: What is the history of vitamin d treating TB&lt;/strong>&lt;/p>
&lt;p>The use of vitamin D in treating tuberculosis (TB) has a fascinating history that intertwines with the broader understanding of vitamin D&amp;rsquo;s role in human health.&lt;/p>
&lt;p>Early Observations and the Sanatorium Movement: In the late 19th and early 20th centuries, before antibiotics were available, TB was a leading cause of death. During this time, it was observed that sunlight and fresh air seemed to benefit TB patients. This observation led to the sanatorium movement, where patients were treated in facilities with abundant sunlight and fresh air.&lt;/p></description></item><item><title>Evaluating the vitamin D evidence - Heaney</title><link>/posts/evaluating-the-vitamin-d-evidence-heaney.html</link><pubDate>Sat, 25 Dec 2010 00:00:00 +0000</pubDate><guid>/posts/evaluating-the-vitamin-d-evidence-heaney.html</guid><description>&lt;h1 id="a-few-images-from-a-presentation-given-in-london">A few images from a Presentation given in London&lt;/h1>
&lt;h2 id="spantiki-download_filephpfileid1628span-to-see-entire-pdf-file">&lt;span>[tiki-download_file.php?fileId=1628]&lt;/span> to see entire PDF file&lt;/h2>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/snap01-dec.-25-2010.gif" alt="image" style="max-width: 400px;">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/snap02-dec.-25-2010.gif" alt="image" style="max-width: 400px;">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/snap03-dec.-25-2010.gif" alt="image" style="max-width: 400px;">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/snap04-dec.-25-2010.gif" alt="image" style="max-width: 400px;">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/snap05-dec.-25-2010.gif" alt="image" style="max-width: 400px;">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/snap06-dec.-25-2010.gif" alt="image" style="max-width: 400px;">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/snap07-dec.-25-2010.gif" alt="image" style="max-width: 400px;">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/snap08-dec.-25-2010.gif" alt="image" style="max-width: 400px;">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/snap09-dec.-25-2010.gif" alt="image" style="max-width: 400px;">
&lt;hr>
&lt;h1 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h1>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/tiki-index.php">Home page&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/tiki-browse_categories.php?parentId=86&amp;amp;sort_mode=created_desc">All items Strength of Evidence for D&lt;/a> 7 items as of Sept 2011&lt;/p>
&lt;/li>
&lt;/ul></description></item><item><title>Should test TB patients for vitamin D</title><link>/posts/should-test-tb-patients-for-vitamin-d.html</link><pubDate>Mon, 22 Nov 2010 00:00:00 +0000</pubDate><guid>/posts/should-test-tb-patients-for-vitamin-d.html</guid><description>&lt;h1 id="s27-should-routine-screening-for-vitamin-d-deficiency-be-incorporated-into-current-guidelines-for-treatment-of-paediatric-tb-patients">S27 Should routine screening for vitamin d deficiency be incorporated into current guidelines for treatment of paediatric TB patients?&lt;/h1>
&lt;ol>
&lt;li>A Ting, 2. M Jiki, 3. C Bell, 4. C Murray, 5. Z Mughal, 6. F Child; Royal Manchester Children&amp;rsquo;s Hospital, Manchester, UK&lt;/li>
&lt;/ol>
&lt;p>Thorax 2010;65:A15 doi:10.1136/thx.2010.150912.27&lt;/p>
&lt;p>Introduction and Objectives The association between low vitamin D levels and increased severity/susceptibility to TB infection due to suppression of innate immunity is well known. In the United Kingdom, low levels of background ultraviolet B radiation limit the photoconversion of 7 dehydrocholestrol in skin to cholecalciferol (vitamin D3). In addition the majority of paediatric TB cases in the UK occur in non-Caucasian patients who by nature of their skin colour are less able to absorb the UV radiation. Current guidelines do not suggest routine checking of serum 25-dihydroxyvitamin D (25(OH)D); a reliable measure of body stores of vitamin D, in paediatric TB cases and providing Vitamin D supplementation as required. We hypothesised that all paediatric TB patients require screening for Vitamin D deficiency and that many would benefit from supplementation.&lt;/p></description></item><item><title>Increased TB if less than 30 ng or greater than 56 ng of vitamin D</title><link>/posts/increased-tb-if-less-than-30-ng-or-greater-than-56-ng-of-vitamin-d.html</link><pubDate>Sun, 26 Sep 2010 00:00:00 +0000</pubDate><guid>/posts/increased-tb-if-less-than-30-ng-or-greater-than-56-ng-of-vitamin-d.html</guid><description>&lt;h3 id="note-wonder-if-this-greenland-conclusion-is-associated-with-a-hrefpostsinuit-digestive-systems-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-743inuit-digestive-systemsa-which-have-evolved-to-repress-vitamin-d-in-the-gut--due-to-too-much-vitamin-d-in-blubber-etc-have-not-noticed-it-reported-elsewhere">Note: wonder if this Greenland conclusion is associated with &lt;a href="/posts/inuit-digestive-systems" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 743">Inuit digestive systems&lt;/a> which have evolved to repress vitamin D in the gut – due to too much vitamin D in blubber, etc. Have not noticed it reported elsewhere.&lt;/h3>
&lt;h3 id="both-high-and-low-serum-vitamin-d-concentrations-are-associated-with-tuberculosis-a-case-control-study-in-greenland">Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland.&lt;/h3>
&lt;p>Br J Nutr. 2010 Jun 17:1-5.&lt;/p>
&lt;p>Nielsen NO, Skifte T, Andersson M, Wohlfahrt J, Søborg B, Koch A, Melbye M, Ladefoged K.&lt;/p></description></item><item><title>86 percent with TB did not have 30 ng of vitamin D and many were black</title><link>/posts/86-percent-with-tb-did-not-have-30-ng-of-vitamin-d-and-many-were-black.html</link><pubDate>Sat, 18 Sep 2010 00:00:00 +0000</pubDate><guid>/posts/86-percent-with-tb-did-not-have-30-ng-of-vitamin-d-and-many-were-black.html</guid><description>&lt;h1 id="vitamin-d-status-and-antimicrobial-peptide-cathelicidin-ll-37-concentrations-in-patients-with-active-pulmonary-tuberculosis">Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis.&lt;/h1>
&lt;p>Am J Clin Nutr. 2010 Sep;92(3):603-11. Epub 2010 Jul 7.&lt;/p>
&lt;p>Yamshchikov AV, Kurbatova EV, Kumari M, Blumberg HM, Ziegler TR, Ray SM, Tangpricha V.&lt;/p>
&lt;p>Department of Medicine, Emory University, Atlanta, GA, USA. &lt;a href="mailto:ayamshchikov@gmail.com">ayamshchikov@gmail.com&lt;/a>&lt;/p>
&lt;p>BACKGROUND: Vitamin D insufficiency is common in industrialized and developing nations. Recent studies have shown that vitamin D insufficiency is associated with a higher risk of active tuberculosis. Laboratory studies provided a mechanism for this link on the basis of findings that vitamin D metabolites regulate the expression of &lt;strong>cathelicidin (LL-37)&lt;/strong> , which is an endogenous antimicrobial peptide with activity against Mycobacterium tuberculosis. Little information is available on the clinical relation between vitamin D, LL-37 concentrations, and disease severity in patients with tuberculosis.&lt;/p></description></item><item><title>TB and vitamin D updated review and meta-analysis – plays a role</title><link>/posts/tb-and-vitamin-d-updated-review-and-meta-analysis-plays-a-role.html</link><pubDate>Mon, 09 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/tb-and-vitamin-d-updated-review-and-meta-analysis-plays-a-role.html</guid><description>&lt;h1 id="vitamin-d-receptor-genetic-polymorphisms-and-tuberculosis-updated-systematic-review-and-meta-analysis">Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis.&lt;/h1>
&lt;p>Int J Tuberc Lung Dis. 2010 Jan;14(1):15-23.&lt;/p>
&lt;p>Gao L, Tao Y, Zhang L, Jin Q.&lt;/p>
&lt;p>Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp;amp; Peking Union Medical College, Beijing, China.&lt;/p>
&lt;p>BACKGROUND: Host genetic susceptibility has been suggested as one of the most important explanations for inter-individual differences in tuberculosis (TB) risk. The vitamin D receptor (VDR) gene has been studied as a candidate locus due to genetic polymorphisms that affects the activity of the receptor and subsequent downstream vitamin D-mediated effects.&lt;/p></description></item><item><title>TB associated with low vitamin D in a review and meta-analysis – 2008</title><link>/posts/tb-associated-with-low-vitamin-d-in-a-review-and-meta-analysis-2008.html</link><pubDate>Mon, 09 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/tb-associated-with-low-vitamin-d-in-a-review-and-meta-analysis-2008.html</guid><description>&lt;h1 id="low-serum-vitamin-d-levels-and-tuberculosis-a-systematic-review-and-meta-analysis">Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis.&lt;/h1>
&lt;p>Int J Epidemiol. 2008 Feb;37(1):113-9.&lt;/p>
&lt;p>Nnoaham KE, Clarke A.&lt;/p>
&lt;p>Department of Public Health, Oxfordshire Primary Care Trust, Richard Building, Old Road Campus, Headington, Oxford OX3 7LG, UK. &lt;a href="mailto:kcnnoaham@yahoo.com">kcnnoaham@yahoo.com&lt;/a>&lt;/p>
&lt;p>OBJECTIVE: To explore the association between low serum vitamin D and risk of active tuberculosis in humans. DESIGN: Systematic review and meta-analysis.&lt;/p>
&lt;p>DATA SOURCES: Observational studies published between 1980 and July 2006 (identified through Medline) that examined the association between low serum vitamin D and risk of active tuberculosis.&lt;/p></description></item><item><title>TB helped by vitamin D</title><link>/posts/tb-helped-by-vitamin-d.html</link><pubDate>Mon, 09 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/tb-helped-by-vitamin-d.html</guid><description>&lt;h1 id="vitamin-d-deficiency-linked-to-tuberculosis-progression-in-healthy-patients">Vitamin D Deficiency Linked to Tuberculosis Progression in Healthy Patients&lt;/h1>
&lt;p>From &lt;a href="http://www.medscape.com/viewarticle/721084">http://www.medscape.com/viewarticle/721084&lt;/a> Howard Bell&lt;/p>
&lt;p>April 30, 2010 — Low vitamin D levels are associated with a 5-fold increased risk for tuberculosis (TB) disease progression in previously healthy household contacts of patients with TB, according to the results of a 4-year cohort follow-up study in Pakistan, reported in the May issue of Emerging Infectious Diseases.&lt;/p>
&lt;p>&amp;ldquo;Deficiency of vitamin D (25-hydroxycholecalciferol) has long been implicated in activation of &lt;span>[TB]&lt;/span>,&amp;rdquo; write Najeeha Talat from Aga Khan University in Karachi, Pakistan, and colleagues. However, disease progression in healthy patients has not been previously studied.&lt;/p></description></item><item><title>TB in Wikipedia from a vitamin D perspective</title><link>/posts/tb-in-wikipedia-from-a-vitamin-d-perspective.html</link><pubDate>Mon, 09 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/tb-in-wikipedia-from-a-vitamin-d-perspective.html</guid><description>&lt;h1 id="phrases-clipped-from-httpenwikipediaorgwikituberculosis">Phrases clipped from &lt;a href="http://en.wikipedia.org/wiki/Tuberculosis">http://en.wikipedia.org/wiki/Tuberculosis&lt;/a>&lt;/h1>
&lt;p>A third of the world&amp;rsquo;s population are thought to be infected with M. tuberculosis, the absolute number of new cases is still increasing&lt;/p>
&lt;p>Persons with chronic renal failure who are on hemodialysis also have an increased risk: 10—25 times greater than the general population &lt;strong>(both extremely low on vitamin D)&lt;/strong>&lt;/p>
&lt;p>Currently, there are more cases of TB on the planet than at any other time in history &lt;strong>(there has been a vitamin D deficiency epidemic of the past 20 years)&lt;/strong>&lt;/p></description></item><item><title>TB not helped by 300000 IU Vitamin D2</title><link>/posts/tb-not-helped-by-300000-iu-vitamin-d2.html</link><pubDate>Mon, 09 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/tb-not-helped-by-300000-iu-vitamin-d2.html</guid><description>&lt;h1 id="in-a-randomized-double-blind-study-conducted-in-guinea-bissau-300000-iu-of-cholecalciferol-had-no-effect-on-clinical-outcome">In a randomized, double-blind study conducted in Guinea-Bissau, 300,000 IU of cholecalciferol had no effect on clinical outcome.&lt;/h1>
&lt;p>From &lt;a href="http://infectious-diseases.jwatch.org/cgi/content/full/2009/520/1">http://infectious-diseases.jwatch.org/cgi/content/full/2009/520/1&lt;/a>&lt;/p>
&lt;p>Vitamin D metabolites have been shown to induce macrophage activity against Mycobacterium tuberculosis in vitro, and supplementation was used to treat TB during the preantibiotic era. In addition, two recent small studies have suggested that vitamin D supplementation provides clinical benefit in patients with active TB.&lt;/p>
&lt;p>To examine whether such supplementation might improve clinical response to treatment, researchers performed a randomized, double-blind, placebo-controlled study in Guinea-Bissau among 365 adults with active pulmonary TB who were initiating antituberculosis therapy. Among these, 281 had follow-up at 12 months. The treatment group received 100,000 IU of cholecalciferol on enrollment and again at 5 and 8 months.&lt;/p></description></item><item><title>TB probability increased 5X when have low vitamin D</title><link>/posts/tb-probability-increased-5x-when-have-low-vitamin-d.html</link><pubDate>Mon, 09 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/tb-probability-increased-5x-when-have-low-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-deficiency-linked-to-tuberculosis-progression-in-healthy-patients">Vitamin D Deficiency Linked to Tuberculosis Progression in Healthy Patients&lt;/h3>
&lt;p>From &lt;a href="http://www.medscape.com/viewarticle/721084">http://www.medscape.com/viewarticle/721084&lt;/a> Howard Bell&lt;/p>
&lt;p>April 30, 2010 — Low vitamin D levels are associated with a 5-fold increased risk for tuberculosis (TB) disease progression in previously healthy household contacts of patients with TB, according to the results of a 4-year cohort follow-up study in Pakistan, reported in the May issue of Emerging Infectious Diseases.&lt;/p>
&lt;p>&amp;ldquo;Deficiency of vitamin D (25-hydroxycholecalciferol) has long been implicated in activation of &lt;span>[TB]&lt;/span>,&amp;rdquo; write Najeeha Talat from Aga Khan University in Karachi, Pakistan, and colleagues. However, disease progression in healthy patients has not been previously studied.&lt;/p></description></item><item><title>TB associated with low level of vitamin D in Pakistan</title><link>/posts/tb-associated-with-low-level-of-vitamin-d-in-pakistan.html</link><pubDate>Thu, 29 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/tb-associated-with-low-level-of-vitamin-d-in-pakistan.html</guid><description>&lt;p>ISSN: 1080-6059&lt;/p>
&lt;p>&lt;a href="http://www.cdc.gov/ncidod/eid/index.htm">EID Journal Home&lt;/a>&amp;gt; &lt;a href="http://www.cdc.gov/EID/content/16/5/contents_v16n5.htm">Volume 16, Number 5–May 2010&lt;/a>&lt;/p>
&lt;h2 id="volume-16-number-5may-2010">Volume 16, Number 5–May 2010&lt;/h2>
&lt;h1 id="vitamin-d-deficiency-and-tuberculosis-progression">Vitamin D Deficiency and Tuberculosis Progression&lt;/h1>
&lt;p>&lt;strong>Najeeha Talat, Sharon Perry, Julie Parsonnet, Ghaffar Dawood, and Rabia Hussain&lt;/strong> &lt;a href="http://www.cdc.gov/EID/content/16/5/853.htm#comment">&lt;img src="http://www.cdc.gov/EID/images/cdc/icon_email.gif" alt="Comments" width="12" height="9">&lt;/a>&lt;/p>
&lt;p>Author affiliations: Aga Khan University, Karachi, Pakistan (N. Talat, R. Hussain); Stanford University School of Medicine, Stanford, California, USA (S. Perry, J. Parsonnet); and Masoomeen General Hospital, Karachi, Pakistan (G. Dawood)&lt;/p>
&lt;p>&lt;a href="http://www.cdc.gov/EID/content/16/5/853.htm#cit">Suggested citation for this article&lt;/a>&lt;/p>
&lt;p>&lt;strong>Abstract&lt;/strong>&lt;/p>
&lt;p>To assess the association between vitamin D deficiency and tuberculosis disease progression, we studied vitamin D levels in a cohort of tuberculosis patients and their contacts (N = 129) in Pakistan. Most (79%) persons showed deficiency. Low vitamin D levels were associated with a 5-fold increased risk for progression to tuberculosis.&lt;/p></description></item><item><title>TB reduced by vitamin D – a doubt</title><link>/posts/tb-reduced-by-vitamin-d-a-doubt.html</link><pubDate>Wed, 28 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/tb-reduced-by-vitamin-d-a-doubt.html</guid><description>&lt;h1 id="vitamin-d-and-host-resistance-to-infection-putting-the-cart-in-front-of-the-horse">Vitamin D and host resistance to infection? Putting the cart in front of the horse.&lt;/h1>
&lt;p>Experimental Biology and Medicine 235(8):921-7 (2010)&lt;/p>
&lt;p>profile Danny Bruce, profile Jot Hui Ooi, profile Sanhong Yu and profile Margherita T Cantorna&lt;/p>
&lt;p>Department of Veterinary and Biomedical Science, Center for Molecular Immunology and Infectious Disease, The Pennsylvania State University, 115 Henning Bldg, University Park, PA 16802, USA.&lt;/p>
&lt;p>Vitamin D is being touted as an anti-infective agent and it has even been suggested that vitamin D supplementation could be effective against the H1N1 influenza virus. The claims are largely based on the ability of vitamin D to induce antibacterial peptides and evidence that the immune system produces active vitamin D (1,25(OH)(2)D(3)) in situ. While there are many examples of immune production of 1,25(OH)(2)D(3) in vitro, &lt;strong>there is little in vivo evidence&lt;/strong> . In addition, it is not clear what role immune production of 1,25(OH)(2)D(3) has on the course of disease. Vitamin D and 1,25(OH)(2)D(3) inhibit T helper type 1 (Th1)/Th17-mediated immune responses and autoimmune diseases by acting on the innate and acquired immune system to inhibit the function of Th1 and Th17 cells. Th1 and Th17 cells are important in host resistance to many infections including tuberculosis (TB) caused by Mycobacterium tuberculosis. Paradoxically the innate immune system is induced to produce antibacterial peptides that are effective against TB in vitro. Data from several models of infection have so far not supported a role for vitamin D in affecting the course of disease. There is also very little evidence that vitamin D affects the course of human TB infection. Experiments have not been done in cells, mice or humans to evaluate the effect of vitamin D on influenza virus.&lt;/p></description></item><item><title>Prisoners have very low vitamin D and get TB, influenza, and depression</title><link>/posts/prisoners-have-very-low-vitamin-d-and-get-tb-influenza-and-depression.html</link><pubDate>Fri, 02 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/prisoners-have-very-low-vitamin-d-and-get-tb-influenza-and-depression.html</guid><description>&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/prision-cartoon.jpg" alt="image">
&lt;p>&lt;strong>Summary: Benefits of giving vitamin D to prisoners appear to include&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Decreased chronic diseases, flu, TB, HIV&lt;br>
Decreased violence (Omega-3 also helps, perhaps even more)&lt;br>
Decreased health problems due to smoking&lt;br>
Decreased pain, depression, suicide&lt;br>
Decreased annual cost/prisoner (due to reduced violence and sickness)&lt;br>
    &lt;span style="color:#F00;">= $ saved, especially by commercial prisons&lt;/span>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#14-ng-if-prisoner-for--1-year-26-ng-if--6-weeks---nov-2014">14 ng if prisoner for &amp;gt; 1 year: 26 ng if &amp;lt; 6 weeks - Nov 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-vitamin-d-status-of-prison-inmates---march-2014">The vitamin D status of prison inmates - March 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#avoid-flu-from-betterbonescomhttpwwwbetterbonescombonenutritionvitamind-swineflupreventionaspx--feb-2010">Avoid flu: from &lt;a href="http://www.betterbones.com/bonenutrition/vitamind-swinefluprevention.aspx">BetterBones.com&lt;/a> Feb 2010&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#23-x-more-tbclipped-from-physorg-dec-2010httpwwwphysorgcomnews2010-12-tb-prisons-incidence-populationhtml">23 X more TB:clipped from &lt;a href="http://www.physorg.com/news/2010-12-tb-prisons-incidence-population.html">Physorg Dec 2010&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#suicide-rate-9x-higher-for-females-in-prison">Suicide rate 9X higher for females in prison&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#alzheimer-increase-2x-faster-among-prisoners---feb-2012">Alzheimer increase 2X faster among Prisoners - Feb 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cdc-look-at-health-in-correctional-facilitieshttpwwwcdcgovcorrectionalhealthhealth-datahtml">&lt;a href="http://www.cdc.gov/correctionalhealth/health-data.html">CDC look at health in Correctional Facilities&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamins-against-violence-aggressive-dutch-inmates-to-get-health-kickhttpsmedicalxpresscomnews2015-09-vitamins-violence-aggressive-dutch-inmateshtml-2015">&lt;a href="https://medicalxpress.com/news/2015-09-vitamins-violence-aggressive-dutch-inmates.html">Vitamins against violence: aggressive Dutch inmates to get health kick&lt;/a> 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#diet-vitamin-program-for-jail-inmates---1975">Diet-Vitamin Program for Jail Inmates - 1975&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#corrective-nutrition---how-vitamins-for-convicts-would-save-taxpayers-money---dec-2017">CORRECTIVE NUTRITION - How vitamins for convicts would save taxpayers&amp;rsquo; money - Dec 2017&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="14-ng-if-prisoner-for--1-year-26-ng-if--6-weeks---nov-2014">14 ng if prisoner for &amp;gt; 1 year: 26 ng if &amp;lt; 6 weeks - Nov 2014&lt;/h3>
&lt;p>&lt;strong>90% &amp;lt; 20 ng if prisoner for &amp;gt; 1 year&lt;/strong>&lt;/p></description></item><item><title>Disease Database - nice links for TB</title><link>/posts/disease-database-nice-links-for-tb.html</link><pubDate>Thu, 01 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/disease-database-nice-links-for-tb.html</guid><description>&lt;p>&lt;a href="http://www.diseasesdatabase.com/links1.asp?glngUserChoice=8515">&lt;a href="https://www.diseasesdatabase.com/links1.asp">www.diseasesdatabase.com/links1.asp&lt;/a>&lt;/a>fom: &lt;br />&lt;/p>
&lt;br />
&lt;p>Links for &lt;a href="http://www.diseasesdatabase.com/ddb8515.htm">Mycobacterium tuberculosis&lt;/a>.&lt;br />&lt;/p>
&lt;p>&amp;#160;&lt;/p>
&lt;table border="1">
&lt;tbody>
&lt;tr>
&lt;th>Site&lt;/th>
&lt;th>Link and description&lt;/th>
&lt;th>Content&lt;/th>
&lt;th>About&lt;/th>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/787841-overview">Tuberculosis: eMedicine Emergency Medicine&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=4928">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/436053-overview">Epididymal Tuberculosis: eMedicine Urology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=17014">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/1202960-overview">Tuberculosis: eMedicine Ophthalmology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=20006">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/969401-overview">Tuberculosis: eMedicine Pediatrics: General Medicine&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=20284">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/230802-overview">Tuberculosis: eMedicine Infectious Diseases&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=14395">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>GPnotebook&lt;/td>
&lt;td>&lt;a class="external" href="http://www.gpnotebook.co.uk/simplepage.cfm?ID=-1556807680">tuberculosis - General Practice Notebook&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=23546">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>World Health Org&lt;/td>
&lt;td>&lt;a class="external" href="http://www.who.int/mediacentre/factsheets/fs104/en/">WHO | Tuberculosis&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=60008">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab004532.html">Routine surgery in addition to chemotherapy for treating spinal tuberculosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=53089">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab005159.html">Rifabutin for treating pulmonary tuberculosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=59027">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab003343.html">Directly observed therapy for treating tuberculosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=16842">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab002244.html">Corticosteroids for managing tuberculous meningitis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=59797">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab000171.html">Treatment of latent tuberculosis infection in HIV infected persons&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=5866">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab000526.html">Interventions for treating tuberculous pericarditis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=6057">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab000970.html">Fully intermittent dosing with drugs for treating tuberculosis in adults&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=6100">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab001166.html">Mycobacterium vaccae immunotherapy for treating tuberculosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=6206">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab001362.html">Regimens of less than six months for treating tuberculosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=6275">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab001363.html">Isoniazid for preventing tuberculosis in non-HIV infected persons&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=6276">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab001876.html">Corticosteroids for tuberculous pleurisy&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=6366">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=4468">Tuberculosis, MedPix™ : 4468 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=518">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>NICE&lt;/td>
&lt;td>&lt;a class="external" href="http://www.nice.org.uk/Guidance/CG33">Tuberculosis&lt;/a>&lt;/td>
&lt;td>Clinical management guideline&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=59138">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;/tbody>
&lt;/table>
&lt;hr />
&lt;h3>Search elsewhere for Mycobacterium tuberculosis&lt;/h3>
&lt;p>&lt;noscript>&lt;b class='look'>JavaScript must be enabled for some links on this page.&lt;/b>&lt;/noscript>&lt;/p></description></item><item><title>Anti-bacterial action of vitamin D</title><link>/posts/anti-bacterial-action-of-vitamin-d.html</link><pubDate>Tue, 01 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/anti-bacterial-action-of-vitamin-d.html</guid><description>&lt;p>Endocrine Abstracts, Published by BioScientifica, Society for Endocrinology BES 2010, Manchester, UK&lt;/p>
&lt;p>15 March 2010 - 18 March 2010, Society for Endocrinology, British Endocrine Societies&lt;/p>
&lt;p>Endocrine Abstracts (2010) 21 S5.2&lt;/p>
&lt;p>Martin Hewison&lt;/p>
&lt;p>University of California Los Angeles, Los Angeles, California, USA.&lt;/p>
&lt;p>Immunomodulatory properties of vitamin D have been recognized for more than 25 years. However, until recently it was unclear whether these actions of contributed to normal immune function. Two new developments have helped to clarify this.&lt;/p></description></item></channel></rss>